{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyNZJbseUNFo+djrjiYdsfqe",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/fangya18/Data-science/blob/master/L1.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KMaKJQmNVGcP",
        "outputId": "9091ac61-2a38-4746-d50f-71d86c962ef8"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at /content/drive\n"
          ]
        }
      ],
      "source": [
        "\n",
        "# authenticate Bigquery and Google Drive\n",
        "from google.colab import auth\n",
        "auth.authenticate_user()\n",
        "\n",
        "# mount your drive\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive')\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "import numpy as np\n",
        "import pandas as pd\n",
        "import datetime as dt\n",
        "import re\n",
        "import matplotlib.pyplot as plt\n",
        "from collections import Counter\n",
        "import seaborn as sns\n",
        "from sklearn.linear_model import LinearRegression"
      ],
      "metadata": {
        "id": "kTOee4_lVXHB"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "cd drive/MyDrive/HU/lymphoma/"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Ahg0LrIEVZlt",
        "outputId": "70776509-8f92-4d7e-f585-e72a1373e381"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "/content/drive/MyDrive/HU/lymphoma\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "df = pd.read_csv('LP1.csv')\n",
        "df.head()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 751
        },
        "id": "k5aqcgc_VfZJ",
        "outputId": "aa39101b-5090-4da6-e4dc-70548670556e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   Rank   NCT Number                                              Title  \\\n",
              "0     1  NCT03415399  Clinical Study of ET190L1 ARTEMIS™ in Relapsed...   \n",
              "1     2  NCT01334502  Everolimus, Rituximab, and Combination Chemoth...   \n",
              "2     3  NCT03039114  Study Evaluating Safety and Efficacy of INCB05...   \n",
              "3     4  NCT04103905  A Study of MIL62 in Treatment of CD20 Positive...   \n",
              "4     5  NCT02741388  A Phase Ib Study of Oral Selinexor in Adult Pa...   \n",
              "\n",
              "   Acronym     Status         Study Results  \\\n",
              "0      NaN  Completed  No Results Available   \n",
              "1      NaN  Completed  No Results Available   \n",
              "2      NaN  Completed  No Results Available   \n",
              "3      NaN  Completed  No Results Available   \n",
              "4  SELINDA  Completed  No Results Available   \n",
              "\n",
              "                                  Conditions  \\\n",
              "0                           Lymphoma, B-Cell   \n",
              "1                                   Lymphoma   \n",
              "2                                   Lymphoma   \n",
              "3  CD20-positive B Cell Non-Hodgkin Lymphoma   \n",
              "4                            B-cell Lymphoma   \n",
              "\n",
              "                                       Interventions  \\\n",
              "0               Biological: ET190L1 ARTEMIS™ T cells   \n",
              "1  Biological: rituximab|Drug: cyclophosphamide|D...   \n",
              "2       Drug: Parsaclisib|Drug: Hexal|Drug: Gazyvaro   \n",
              "3  Drug: Recombinant Humanized Monoclonal Antibod...   \n",
              "4  Drug: selinexor|Drug: Rituximab|Drug: Dexameth...   \n",
              "\n",
              "                                    Outcome Measures  \\\n",
              "0  Maximum Tolerated Dose|Toxicity profile of ET1...   \n",
              "1  MTD of everolimus in combination with R-CHOP|A...   \n",
              "2  Safety and tolerability of parsaclisib in comb...   \n",
              "3  Percentage of Participants Who Experienced a D...   \n",
              "4  Incidence rate of dose-limiting toxicities (DL...   \n",
              "\n",
              "                               Sponsor/Collaborators  ...  \\\n",
              "0         Eureka Therapeutics Inc.|Peking University  ...   \n",
              "1  Alliance for Clinical Trials in Oncology|Natio...  ...   \n",
              "2                                 Incyte Corporation  ...   \n",
              "3                 Beijing Mabworks Biotech Co., Ltd.  ...   \n",
              "4  The Lymphoma Academic Research Organisation|Ka...  ...   \n",
              "\n",
              "                                  Other IDs         Start Date  \\\n",
              "0                           ETCH17CD19AR103  September 9, 2017   \n",
              "1  NCCTG-N1085|CDR0000698584|NCI-2011-02643         March 2012   \n",
              "2  INCB 50465-102 (CITADEL-102)|Parsaclisib  February 15, 2017   \n",
              "3                                MIL62-CT01  February 10, 2017   \n",
              "4                                   SELINDA       October 2016   \n",
              "\n",
              "  Primary Completion Date     Completion Date        First Posted  \\\n",
              "0       December 31, 2020   December 31, 2020    January 30, 2018   \n",
              "1           February 2015         August 2017      April 13, 2011   \n",
              "2          March 30, 2021      March 30, 2021    February 1, 2017   \n",
              "3            May 30, 2019        May 29, 2020  September 26, 2019   \n",
              "4      September 29, 2021  September 29, 2021      April 18, 2016   \n",
              "\n",
              "  Results First Posted Last Update Posted  \\\n",
              "0                  NaN     March 16, 2021   \n",
              "1                  NaN    August 10, 2017   \n",
              "2                  NaN   December 2, 2021   \n",
              "3                  NaN      June 16, 2021   \n",
              "4                  NaN   December 7, 2021   \n",
              "\n",
              "                                           Locations Study Documents  \\\n",
              "0  Peking University Cancer Hospital, Beijing, China             NaN   \n",
              "1  Mayo Clinic Cancer Center, Rochester, Minnesot...             NaN   \n",
              "2  Banner Health, Gilbert, Arizona, United States...             NaN   \n",
              "3  Chinese Academy of Medical Sciences (CAMS) & P...             NaN   \n",
              "4  Institut Jules Bordet, Bruxelles, Belgium|CHU ...             NaN   \n",
              "\n",
              "                                           URL  \n",
              "0  https://ClinicalTrials.gov/show/NCT03415399  \n",
              "1  https://ClinicalTrials.gov/show/NCT01334502  \n",
              "2  https://ClinicalTrials.gov/show/NCT03039114  \n",
              "3  https://ClinicalTrials.gov/show/NCT04103905  \n",
              "4  https://ClinicalTrials.gov/show/NCT02741388  \n",
              "\n",
              "[5 rows x 27 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-2a8b2904-2380-4710-9850-bcafe9be1cbc\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Rank</th>\n",
              "      <th>NCT Number</th>\n",
              "      <th>Title</th>\n",
              "      <th>Acronym</th>\n",
              "      <th>Status</th>\n",
              "      <th>Study Results</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>Interventions</th>\n",
              "      <th>Outcome Measures</th>\n",
              "      <th>Sponsor/Collaborators</th>\n",
              "      <th>...</th>\n",
              "      <th>Other IDs</th>\n",
              "      <th>Start Date</th>\n",
              "      <th>Primary Completion Date</th>\n",
              "      <th>Completion Date</th>\n",
              "      <th>First Posted</th>\n",
              "      <th>Results First Posted</th>\n",
              "      <th>Last Update Posted</th>\n",
              "      <th>Locations</th>\n",
              "      <th>Study Documents</th>\n",
              "      <th>URL</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>1</td>\n",
              "      <td>NCT03415399</td>\n",
              "      <td>Clinical Study of ET190L1 ARTEMIS™ in Relapsed...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Completed</td>\n",
              "      <td>No Results Available</td>\n",
              "      <td>Lymphoma, B-Cell</td>\n",
              "      <td>Biological: ET190L1 ARTEMIS™ T cells</td>\n",
              "      <td>Maximum Tolerated Dose|Toxicity profile of ET1...</td>\n",
              "      <td>Eureka Therapeutics Inc.|Peking University</td>\n",
              "      <td>...</td>\n",
              "      <td>ETCH17CD19AR103</td>\n",
              "      <td>September 9, 2017</td>\n",
              "      <td>December 31, 2020</td>\n",
              "      <td>December 31, 2020</td>\n",
              "      <td>January 30, 2018</td>\n",
              "      <td>NaN</td>\n",
              "      <td>March 16, 2021</td>\n",
              "      <td>Peking University Cancer Hospital, Beijing, China</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://ClinicalTrials.gov/show/NCT03415399</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>2</td>\n",
              "      <td>NCT01334502</td>\n",
              "      <td>Everolimus, Rituximab, and Combination Chemoth...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Completed</td>\n",
              "      <td>No Results Available</td>\n",
              "      <td>Lymphoma</td>\n",
              "      <td>Biological: rituximab|Drug: cyclophosphamide|D...</td>\n",
              "      <td>MTD of everolimus in combination with R-CHOP|A...</td>\n",
              "      <td>Alliance for Clinical Trials in Oncology|Natio...</td>\n",
              "      <td>...</td>\n",
              "      <td>NCCTG-N1085|CDR0000698584|NCI-2011-02643</td>\n",
              "      <td>March 2012</td>\n",
              "      <td>February 2015</td>\n",
              "      <td>August 2017</td>\n",
              "      <td>April 13, 2011</td>\n",
              "      <td>NaN</td>\n",
              "      <td>August 10, 2017</td>\n",
              "      <td>Mayo Clinic Cancer Center, Rochester, Minnesot...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://ClinicalTrials.gov/show/NCT01334502</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>3</td>\n",
              "      <td>NCT03039114</td>\n",
              "      <td>Study Evaluating Safety and Efficacy of INCB05...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Completed</td>\n",
              "      <td>No Results Available</td>\n",
              "      <td>Lymphoma</td>\n",
              "      <td>Drug: Parsaclisib|Drug: Hexal|Drug: Gazyvaro</td>\n",
              "      <td>Safety and tolerability of parsaclisib in comb...</td>\n",
              "      <td>Incyte Corporation</td>\n",
              "      <td>...</td>\n",
              "      <td>INCB 50465-102 (CITADEL-102)|Parsaclisib</td>\n",
              "      <td>February 15, 2017</td>\n",
              "      <td>March 30, 2021</td>\n",
              "      <td>March 30, 2021</td>\n",
              "      <td>February 1, 2017</td>\n",
              "      <td>NaN</td>\n",
              "      <td>December 2, 2021</td>\n",
              "      <td>Banner Health, Gilbert, Arizona, United States...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://ClinicalTrials.gov/show/NCT03039114</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>4</td>\n",
              "      <td>NCT04103905</td>\n",
              "      <td>A Study of MIL62 in Treatment of CD20 Positive...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Completed</td>\n",
              "      <td>No Results Available</td>\n",
              "      <td>CD20-positive B Cell Non-Hodgkin Lymphoma</td>\n",
              "      <td>Drug: Recombinant Humanized Monoclonal Antibod...</td>\n",
              "      <td>Percentage of Participants Who Experienced a D...</td>\n",
              "      <td>Beijing Mabworks Biotech Co., Ltd.</td>\n",
              "      <td>...</td>\n",
              "      <td>MIL62-CT01</td>\n",
              "      <td>February 10, 2017</td>\n",
              "      <td>May 30, 2019</td>\n",
              "      <td>May 29, 2020</td>\n",
              "      <td>September 26, 2019</td>\n",
              "      <td>NaN</td>\n",
              "      <td>June 16, 2021</td>\n",
              "      <td>Chinese Academy of Medical Sciences (CAMS) &amp; P...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://ClinicalTrials.gov/show/NCT04103905</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>5</td>\n",
              "      <td>NCT02741388</td>\n",
              "      <td>A Phase Ib Study of Oral Selinexor in Adult Pa...</td>\n",
              "      <td>SELINDA</td>\n",
              "      <td>Completed</td>\n",
              "      <td>No Results Available</td>\n",
              "      <td>B-cell Lymphoma</td>\n",
              "      <td>Drug: selinexor|Drug: Rituximab|Drug: Dexameth...</td>\n",
              "      <td>Incidence rate of dose-limiting toxicities (DL...</td>\n",
              "      <td>The Lymphoma Academic Research Organisation|Ka...</td>\n",
              "      <td>...</td>\n",
              "      <td>SELINDA</td>\n",
              "      <td>October 2016</td>\n",
              "      <td>September 29, 2021</td>\n",
              "      <td>September 29, 2021</td>\n",
              "      <td>April 18, 2016</td>\n",
              "      <td>NaN</td>\n",
              "      <td>December 7, 2021</td>\n",
              "      <td>Institut Jules Bordet, Bruxelles, Belgium|CHU ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://ClinicalTrials.gov/show/NCT02741388</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows × 27 columns</p>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2a8b2904-2380-4710-9850-bcafe9be1cbc')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-2a8b2904-2380-4710-9850-bcafe9be1cbc button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-2a8b2904-2380-4710-9850-bcafe9be1cbc');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 4
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df.columns = df.columns.str.lower()"
      ],
      "metadata": {
        "id": "mnioilnvVowJ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df[['start date','completion date']] = df[['start date','completion date']].apply(pd.to_datetime)\n",
        "df['duration'] = (df['completion date'] - df['start date']).dt.days"
      ],
      "metadata": {
        "id": "UEdPMXICWItT"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df.columns"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Q1oXSSrkWUJ0",
        "outputId": "eb6fc1dd-ca64-4243-a1e3-7e611aab691f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Index(['rank', 'nct number', 'title', 'acronym', 'status', 'study results',\n",
              "       'conditions', 'interventions', 'outcome measures',\n",
              "       'sponsor/collaborators', 'gender', 'age', 'phases', 'enrollment',\n",
              "       'funded bys', 'study type', 'study designs', 'other ids', 'start date',\n",
              "       'primary completion date', 'completion date', 'first posted',\n",
              "       'results first posted', 'last update posted', 'locations',\n",
              "       'study documents', 'url', 'duration'],\n",
              "      dtype='object')"
            ]
          },
          "metadata": {},
          "execution_count": 7
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df1= df[['title','interventions','duration','gender','age','enrollment','sponsor/collaborators']]\n",
        "df1['sponsor/collaborators']=df['sponsor/collaborators'].str.lower()\n",
        "df1['age']=df['age'].str.lower()\n",
        "df1['title']=df['title'].str.lower()\n",
        "df1['interventions']=df['interventions'].str.lower()\n",
        "df1.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 731
        },
        "id": "cbLSaDoiWWiy",
        "outputId": "53e913b0-1324-49cb-8d08-734a57bd722f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-7-22b6d3e940e2>:2: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1['sponsor/collaborators']=df['sponsor/collaborators'].str.lower()\n",
            "<ipython-input-7-22b6d3e940e2>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1['age']=df['age'].str.lower()\n",
            "<ipython-input-7-22b6d3e940e2>:4: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1['title']=df['title'].str.lower()\n",
            "<ipython-input-7-22b6d3e940e2>:5: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1['interventions']=df['interventions'].str.lower()\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                               title  \\\n",
              "0  clinical study of et190l1 artemis™ in relapsed...   \n",
              "1  everolimus, rituximab, and combination chemoth...   \n",
              "2  study evaluating safety and efficacy of incb05...   \n",
              "3  a study of mil62 in treatment of cd20 positive...   \n",
              "4  a phase ib study of oral selinexor in adult pa...   \n",
              "\n",
              "                                       interventions  duration gender  \\\n",
              "0               biological: et190l1 artemis™ t cells    1209.0    All   \n",
              "1  biological: rituximab|drug: cyclophosphamide|d...    1979.0    All   \n",
              "2       drug: parsaclisib|drug: hexal|drug: gazyvaro    1504.0    All   \n",
              "3  drug: recombinant humanized monoclonal antibod...    1204.0    All   \n",
              "4  drug: selinexor|drug: rituximab|drug: dexameth...    1824.0    All   \n",
              "\n",
              "                                           age  enrollment  \\\n",
              "0    18 years and older   (adult, older adult)         4.0   \n",
              "1    18 years and older   (adult, older adult)        26.0   \n",
              "2    18 years and older   (adult, older adult)        26.0   \n",
              "3    18 years and older   (adult, older adult)        27.0   \n",
              "4  18 years to 70 years   (adult, older adult)        39.0   \n",
              "\n",
              "                               sponsor/collaborators  \n",
              "0         eureka therapeutics inc.|peking university  \n",
              "1  alliance for clinical trials in oncology|natio...  \n",
              "2                                 incyte corporation  \n",
              "3                 beijing mabworks biotech co., ltd.  \n",
              "4  the lymphoma academic research organisation|ka...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-a97b2ef9-2f41-4e6c-8472-6369d434d4a0\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>title</th>\n",
              "      <th>interventions</th>\n",
              "      <th>duration</th>\n",
              "      <th>gender</th>\n",
              "      <th>age</th>\n",
              "      <th>enrollment</th>\n",
              "      <th>sponsor/collaborators</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>clinical study of et190l1 artemis™ in relapsed...</td>\n",
              "      <td>biological: et190l1 artemis™ t cells</td>\n",
              "      <td>1209.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>4.0</td>\n",
              "      <td>eureka therapeutics inc.|peking university</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>everolimus, rituximab, and combination chemoth...</td>\n",
              "      <td>biological: rituximab|drug: cyclophosphamide|d...</td>\n",
              "      <td>1979.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>26.0</td>\n",
              "      <td>alliance for clinical trials in oncology|natio...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>study evaluating safety and efficacy of incb05...</td>\n",
              "      <td>drug: parsaclisib|drug: hexal|drug: gazyvaro</td>\n",
              "      <td>1504.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>26.0</td>\n",
              "      <td>incyte corporation</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>a study of mil62 in treatment of cd20 positive...</td>\n",
              "      <td>drug: recombinant humanized monoclonal antibod...</td>\n",
              "      <td>1204.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>27.0</td>\n",
              "      <td>beijing mabworks biotech co., ltd.</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>a phase ib study of oral selinexor in adult pa...</td>\n",
              "      <td>drug: selinexor|drug: rituximab|drug: dexameth...</td>\n",
              "      <td>1824.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years to 70 years   (adult, older adult)</td>\n",
              "      <td>39.0</td>\n",
              "      <td>the lymphoma academic research organisation|ka...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-a97b2ef9-2f41-4e6c-8472-6369d434d4a0')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-a97b2ef9-2f41-4e6c-8472-6369d434d4a0 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-a97b2ef9-2f41-4e6c-8472-6369d434d4a0');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 7
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Cut Level for duration\n",
        "dcat=pd.cut(df1.duration, bins=[0,366,732,1100,3000],\n",
        "             labels=[\"a1year\", \"a2year\" ,\"a3year\", \"m3year\"])\n",
        "df1.insert(5, \"Dcat\", dcat)\n"
      ],
      "metadata": {
        "id": "vk9F5_VAWhOm"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df1['ecat']= np.where(df1['enrollment']<50, 'Less50','Greater50')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "0VJ0uyKma37Y",
        "outputId": "694b0c8b-fb64-4b2f-f2a0-77db1d5bfe95"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-9-de0aa5b3d4e5>:1: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1['ecat']= np.where(df1['enrollment']<50, 'Less50','Greater50')\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df1.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 337
        },
        "id": "BtCp6JC3Wref",
        "outputId": "aed2438b-97fd-4537-b09d-7a379b558feb"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                               title  \\\n",
              "0  clinical study of et190l1 artemis™ in relapsed...   \n",
              "1  everolimus, rituximab, and combination chemoth...   \n",
              "2  study evaluating safety and efficacy of incb05...   \n",
              "3  a study of mil62 in treatment of cd20 positive...   \n",
              "4  a phase ib study of oral selinexor in adult pa...   \n",
              "\n",
              "                                       interventions  duration gender  \\\n",
              "0               biological: et190l1 artemis™ t cells    1209.0    All   \n",
              "1  biological: rituximab|drug: cyclophosphamide|d...    1979.0    All   \n",
              "2       drug: parsaclisib|drug: hexal|drug: gazyvaro    1504.0    All   \n",
              "3  drug: recombinant humanized monoclonal antibod...    1204.0    All   \n",
              "4  drug: selinexor|drug: rituximab|drug: dexameth...    1824.0    All   \n",
              "\n",
              "                                           age    Dcat  enrollment  \\\n",
              "0    18 years and older   (adult, older adult)  m3year         4.0   \n",
              "1    18 years and older   (adult, older adult)  m3year        26.0   \n",
              "2    18 years and older   (adult, older adult)  m3year        26.0   \n",
              "3    18 years and older   (adult, older adult)  m3year        27.0   \n",
              "4  18 years to 70 years   (adult, older adult)  m3year        39.0   \n",
              "\n",
              "                               sponsor/collaborators    ecat  \n",
              "0         eureka therapeutics inc.|peking university  Less50  \n",
              "1  alliance for clinical trials in oncology|natio...  Less50  \n",
              "2                                 incyte corporation  Less50  \n",
              "3                 beijing mabworks biotech co., ltd.  Less50  \n",
              "4  the lymphoma academic research organisation|ka...  Less50  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-43c22e15-4c19-4150-ab88-37c30cd86323\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>title</th>\n",
              "      <th>interventions</th>\n",
              "      <th>duration</th>\n",
              "      <th>gender</th>\n",
              "      <th>age</th>\n",
              "      <th>Dcat</th>\n",
              "      <th>enrollment</th>\n",
              "      <th>sponsor/collaborators</th>\n",
              "      <th>ecat</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>clinical study of et190l1 artemis™ in relapsed...</td>\n",
              "      <td>biological: et190l1 artemis™ t cells</td>\n",
              "      <td>1209.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>4.0</td>\n",
              "      <td>eureka therapeutics inc.|peking university</td>\n",
              "      <td>Less50</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>everolimus, rituximab, and combination chemoth...</td>\n",
              "      <td>biological: rituximab|drug: cyclophosphamide|d...</td>\n",
              "      <td>1979.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>26.0</td>\n",
              "      <td>alliance for clinical trials in oncology|natio...</td>\n",
              "      <td>Less50</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>study evaluating safety and efficacy of incb05...</td>\n",
              "      <td>drug: parsaclisib|drug: hexal|drug: gazyvaro</td>\n",
              "      <td>1504.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>26.0</td>\n",
              "      <td>incyte corporation</td>\n",
              "      <td>Less50</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>a study of mil62 in treatment of cd20 positive...</td>\n",
              "      <td>drug: recombinant humanized monoclonal antibod...</td>\n",
              "      <td>1204.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>27.0</td>\n",
              "      <td>beijing mabworks biotech co., ltd.</td>\n",
              "      <td>Less50</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>a phase ib study of oral selinexor in adult pa...</td>\n",
              "      <td>drug: selinexor|drug: rituximab|drug: dexameth...</td>\n",
              "      <td>1824.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years to 70 years   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>39.0</td>\n",
              "      <td>the lymphoma academic research organisation|ka...</td>\n",
              "      <td>Less50</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-43c22e15-4c19-4150-ab88-37c30cd86323')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-43c22e15-4c19-4150-ab88-37c30cd86323 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-43c22e15-4c19-4150-ab88-37c30cd86323');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 10
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Enrollement vs Duration\n",
        "1. patients =<50\n",
        "2. patients >50\n",
        "\n",
        "* It makes a difference"
      ],
      "metadata": {
        "id": "LHAkbO2wXEPD"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "def fplot(var,label):\n",
        "    fig, ax=plt.subplots(1,4)\n",
        "    sns.violinplot(x=var, y=\"duration\",data=df1,palette=\"Set2\",ax=ax[0])\n",
        "    sns.histplot(df1,x=\"duration\", hue=var, palette=\"Set2\",kde=True,ax=ax[1])\n",
        "    sns.countplot(x=var,hue=\"Dcat\",data=df1,palette=\"Set2\", ax=ax[2])\n",
        "    sns.barplot(x=var , y=\"duration\",palette=\"Set2\", data=df1,ax=ax[3])\n",
        "    plt.suptitle(label)\n",
        "    return plt\n",
        "fig.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        },
        "id": "njRKY1p_XBW7",
        "outputId": "a6aec460-1df3-4f2d-f5f6-eff397c3d736"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 0 Axes>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fplot(\"ecat\",\"enrollment\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 515
        },
        "id": "cLyWLP-DbhDG",
        "outputId": "df8f4116-eddc-4f24-fc2d-521756f4c171"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<module 'matplotlib.pyplot' from '/usr/local/lib/python3.10/dist-packages/matplotlib/pyplot.py'>"
            ]
          },
          "metadata": {},
          "execution_count": 12
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 4 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"ecat\" , y=\"duration\",palette=\"Set2\", data=df1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "rjk2XCvtY74x",
        "outputId": "d58598d9-4017-47d1-81b2-df399d472fd1"
      },
      "execution_count": 13,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import scipy.stats as stats"
      ],
      "metadata": {
        "id": "_hLwd-MLb1KL"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Sponsor vs Duration\n",
        "1. Industrial or Academic\n",
        "\n",
        "Note: We only count industry solo, collaboration is counted in acdemics"
      ],
      "metadata": {
        "id": "K4ESYz-te-QV"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "values=[\"university\", \"academic\", \"research\" ,\"hospital\", \"organization\"]"
      ],
      "metadata": {
        "id": "VFxke6Hff6Bf"
      },
      "execution_count": 14,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Industry vs Academic\n",
        "df1[\"indcat\"]=np.where(df1[\"sponsor/collaborators\"].str.contains('|'.join(values)),\"CorA\" ,\"IndSolo\")\n",
        "dfa= df1[df1.indcat.isin([\"N\"])]\n",
        "dfb=df1[df1.indcat.isin([\"Y\"])]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "vrwNr60weF80",
        "outputId": "b1945010-375c-401b-eccd-8305c9568215"
      },
      "execution_count": 15,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-15-4ae14a001bcb>:2: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1[\"indcat\"]=np.where(df1[\"sponsor/collaborators\"].str.contains('|'.join(values)),\"CorA\" ,\"IndSolo\")\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df1.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 337
        },
        "id": "IProTq_ggJY1",
        "outputId": "910f3bb9-a1b3-4d1d-e362-9259471f63ac"
      },
      "execution_count": 16,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                               title  \\\n",
              "0  clinical study of et190l1 artemis™ in relapsed...   \n",
              "1  everolimus, rituximab, and combination chemoth...   \n",
              "2  study evaluating safety and efficacy of incb05...   \n",
              "3  a study of mil62 in treatment of cd20 positive...   \n",
              "4  a phase ib study of oral selinexor in adult pa...   \n",
              "\n",
              "                                       interventions  duration gender  \\\n",
              "0               biological: et190l1 artemis™ t cells    1209.0    All   \n",
              "1  biological: rituximab|drug: cyclophosphamide|d...    1979.0    All   \n",
              "2       drug: parsaclisib|drug: hexal|drug: gazyvaro    1504.0    All   \n",
              "3  drug: recombinant humanized monoclonal antibod...    1204.0    All   \n",
              "4  drug: selinexor|drug: rituximab|drug: dexameth...    1824.0    All   \n",
              "\n",
              "                                           age    Dcat  enrollment  \\\n",
              "0    18 years and older   (adult, older adult)  m3year         4.0   \n",
              "1    18 years and older   (adult, older adult)  m3year        26.0   \n",
              "2    18 years and older   (adult, older adult)  m3year        26.0   \n",
              "3    18 years and older   (adult, older adult)  m3year        27.0   \n",
              "4  18 years to 70 years   (adult, older adult)  m3year        39.0   \n",
              "\n",
              "                               sponsor/collaborators    ecat   indcat  \n",
              "0         eureka therapeutics inc.|peking university  Less50     CorA  \n",
              "1  alliance for clinical trials in oncology|natio...  Less50  IndSolo  \n",
              "2                                 incyte corporation  Less50  IndSolo  \n",
              "3                 beijing mabworks biotech co., ltd.  Less50  IndSolo  \n",
              "4  the lymphoma academic research organisation|ka...  Less50     CorA  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-e7b611fa-9a46-46f4-9161-d1f4b917c7cb\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>title</th>\n",
              "      <th>interventions</th>\n",
              "      <th>duration</th>\n",
              "      <th>gender</th>\n",
              "      <th>age</th>\n",
              "      <th>Dcat</th>\n",
              "      <th>enrollment</th>\n",
              "      <th>sponsor/collaborators</th>\n",
              "      <th>ecat</th>\n",
              "      <th>indcat</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>clinical study of et190l1 artemis™ in relapsed...</td>\n",
              "      <td>biological: et190l1 artemis™ t cells</td>\n",
              "      <td>1209.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>4.0</td>\n",
              "      <td>eureka therapeutics inc.|peking university</td>\n",
              "      <td>Less50</td>\n",
              "      <td>CorA</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>everolimus, rituximab, and combination chemoth...</td>\n",
              "      <td>biological: rituximab|drug: cyclophosphamide|d...</td>\n",
              "      <td>1979.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>26.0</td>\n",
              "      <td>alliance for clinical trials in oncology|natio...</td>\n",
              "      <td>Less50</td>\n",
              "      <td>IndSolo</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>study evaluating safety and efficacy of incb05...</td>\n",
              "      <td>drug: parsaclisib|drug: hexal|drug: gazyvaro</td>\n",
              "      <td>1504.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>26.0</td>\n",
              "      <td>incyte corporation</td>\n",
              "      <td>Less50</td>\n",
              "      <td>IndSolo</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>a study of mil62 in treatment of cd20 positive...</td>\n",
              "      <td>drug: recombinant humanized monoclonal antibod...</td>\n",
              "      <td>1204.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>27.0</td>\n",
              "      <td>beijing mabworks biotech co., ltd.</td>\n",
              "      <td>Less50</td>\n",
              "      <td>IndSolo</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>a phase ib study of oral selinexor in adult pa...</td>\n",
              "      <td>drug: selinexor|drug: rituximab|drug: dexameth...</td>\n",
              "      <td>1824.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years to 70 years   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>39.0</td>\n",
              "      <td>the lymphoma academic research organisation|ka...</td>\n",
              "      <td>Less50</td>\n",
              "      <td>CorA</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-e7b611fa-9a46-46f4-9161-d1f4b917c7cb')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-e7b611fa-9a46-46f4-9161-d1f4b917c7cb button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-e7b611fa-9a46-46f4-9161-d1f4b917c7cb');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fplot(\"indcat\",\"Industry\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 515
        },
        "id": "o0LbQNiggN0A",
        "outputId": "c9400622-18d5-4cb3-b768-5d64dd6f8f8b"
      },
      "execution_count": 17,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<module 'matplotlib.pyplot' from '/usr/local/lib/python3.10/dist-packages/matplotlib/pyplot.py'>"
            ]
          },
          "metadata": {},
          "execution_count": 17
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 4 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"indcat\" , y=\"duration\",palette=\"Set2\", data=df1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "UcG8rpblhII_",
        "outputId": "7dfd12e7-6fff-4698-8734-0750c5f08784"
      },
      "execution_count": 18,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Age\n",
        "1. Any study contains Adult or children\n",
        "2. Child solo"
      ],
      "metadata": {
        "id": "0F028t8fht5w"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Adult vs Child Solo\n",
        "pd.set_option(\"max_colwidth\", 200)\n",
        "df1[\"acat\"]=np.where(df1[\"age\"].str.contains(\"adult\"),\"CAdult\" ,\"ChildSolo\")\n",
        "df1.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 583
        },
        "id": "GiPvPfa5hte2",
        "outputId": "ac31ca38-393a-4824-d7a6-55af64c0528e"
      },
      "execution_count": 52,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-52-0d867f14f181>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1[\"acat\"]=np.where(df1[\"age\"].str.contains(\"adult\"),\"CAdult\" ,\"ChildSolo\")\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                                                                                                                                        title  \\\n",
              "0                                                                                  clinical study of et190l1 artemis™ in relapsed, refractory b cell lymphoma   \n",
              "1                       everolimus, rituximab, and combination chemotherapy in treating patients with newly diagnosed untreated diffuse large b-cell lymphoma   \n",
              "2  study evaluating safety and efficacy of incb050465 combined with bendamustine and obinutuzumab in relapsed or refractory follicular lymphoma (citadel-102)   \n",
              "3                                                                                             a study of mil62 in treatment of cd20 positive b-cell lymphomas   \n",
              "4                                    a phase ib study of oral selinexor in adult patients with relapsed/refractory b-cell lymphoma receiving r-dhaox or r-gdp   \n",
              "\n",
              "                                                                                                                              interventions  \\\n",
              "0                                                                                                      biological: et190l1 artemis™ t cells   \n",
              "1  biological: rituximab|drug: cyclophosphamide|drug: doxorubicin hydrochloride|drug: everolimus|drug: prednisone|drug: vincristine sulfate   \n",
              "2                                                                                              drug: parsaclisib|drug: hexal|drug: gazyvaro   \n",
              "3                                                                           drug: recombinant humanized monoclonal antibody mil62 injection   \n",
              "4                  drug: selinexor|drug: rituximab|drug: dexamethasone|drug: oxaliplatin|drug: cisplatin|drug: cytarabine|drug: gemcitabine   \n",
              "\n",
              "   duration gender                                          age    Dcat  \\\n",
              "0    1209.0    All    18 years and older   (adult, older adult)  m3year   \n",
              "1    1979.0    All    18 years and older   (adult, older adult)  m3year   \n",
              "2    1504.0    All    18 years and older   (adult, older adult)  m3year   \n",
              "3    1204.0    All    18 years and older   (adult, older adult)  m3year   \n",
              "4    1824.0    All  18 years to 70 years   (adult, older adult)  m3year   \n",
              "\n",
              "   enrollment  \\\n",
              "0         4.0   \n",
              "1        26.0   \n",
              "2        26.0   \n",
              "3        27.0   \n",
              "4        39.0   \n",
              "\n",
              "                                                      sponsor/collaborators  \\\n",
              "0                                eureka therapeutics inc.|peking university   \n",
              "1  alliance for clinical trials in oncology|national cancer institute (nci)   \n",
              "2                                                        incyte corporation   \n",
              "3                                        beijing mabworks biotech co., ltd.   \n",
              "4   the lymphoma academic research organisation|karyopharm therapeutics inc   \n",
              "\n",
              "     ecat   indcat    acat  \n",
              "0  Less50     CorA  CAdult  \n",
              "1  Less50  IndSolo  CAdult  \n",
              "2  Less50  IndSolo  CAdult  \n",
              "3  Less50  IndSolo  CAdult  \n",
              "4  Less50     CorA  CAdult  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-690b1aed-ac5f-4c7c-a563-3daffaa70ec2\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>title</th>\n",
              "      <th>interventions</th>\n",
              "      <th>duration</th>\n",
              "      <th>gender</th>\n",
              "      <th>age</th>\n",
              "      <th>Dcat</th>\n",
              "      <th>enrollment</th>\n",
              "      <th>sponsor/collaborators</th>\n",
              "      <th>ecat</th>\n",
              "      <th>indcat</th>\n",
              "      <th>acat</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>clinical study of et190l1 artemis™ in relapsed, refractory b cell lymphoma</td>\n",
              "      <td>biological: et190l1 artemis™ t cells</td>\n",
              "      <td>1209.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>4.0</td>\n",
              "      <td>eureka therapeutics inc.|peking university</td>\n",
              "      <td>Less50</td>\n",
              "      <td>CorA</td>\n",
              "      <td>CAdult</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>everolimus, rituximab, and combination chemotherapy in treating patients with newly diagnosed untreated diffuse large b-cell lymphoma</td>\n",
              "      <td>biological: rituximab|drug: cyclophosphamide|drug: doxorubicin hydrochloride|drug: everolimus|drug: prednisone|drug: vincristine sulfate</td>\n",
              "      <td>1979.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>26.0</td>\n",
              "      <td>alliance for clinical trials in oncology|national cancer institute (nci)</td>\n",
              "      <td>Less50</td>\n",
              "      <td>IndSolo</td>\n",
              "      <td>CAdult</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>study evaluating safety and efficacy of incb050465 combined with bendamustine and obinutuzumab in relapsed or refractory follicular lymphoma (citadel-102)</td>\n",
              "      <td>drug: parsaclisib|drug: hexal|drug: gazyvaro</td>\n",
              "      <td>1504.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>26.0</td>\n",
              "      <td>incyte corporation</td>\n",
              "      <td>Less50</td>\n",
              "      <td>IndSolo</td>\n",
              "      <td>CAdult</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>a study of mil62 in treatment of cd20 positive b-cell lymphomas</td>\n",
              "      <td>drug: recombinant humanized monoclonal antibody mil62 injection</td>\n",
              "      <td>1204.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years and older   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>27.0</td>\n",
              "      <td>beijing mabworks biotech co., ltd.</td>\n",
              "      <td>Less50</td>\n",
              "      <td>IndSolo</td>\n",
              "      <td>CAdult</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>a phase ib study of oral selinexor in adult patients with relapsed/refractory b-cell lymphoma receiving r-dhaox or r-gdp</td>\n",
              "      <td>drug: selinexor|drug: rituximab|drug: dexamethasone|drug: oxaliplatin|drug: cisplatin|drug: cytarabine|drug: gemcitabine</td>\n",
              "      <td>1824.0</td>\n",
              "      <td>All</td>\n",
              "      <td>18 years to 70 years   (adult, older adult)</td>\n",
              "      <td>m3year</td>\n",
              "      <td>39.0</td>\n",
              "      <td>the lymphoma academic research organisation|karyopharm therapeutics inc</td>\n",
              "      <td>Less50</td>\n",
              "      <td>CorA</td>\n",
              "      <td>CAdult</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-690b1aed-ac5f-4c7c-a563-3daffaa70ec2')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-690b1aed-ac5f-4c7c-a563-3daffaa70ec2 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-690b1aed-ac5f-4c7c-a563-3daffaa70ec2');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 52
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"acat\" , y=\"duration\",palette=\"Set2\", data=df1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "k6hGUNTti-d4",
        "outputId": "fdff0a38-ddd7-4a0c-ec2b-2dd2b379f276"
      },
      "execution_count": 20,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Title\n",
        "1. Contain Chemotherapy\n",
        "2. Contain Immunotherapy"
      ],
      "metadata": {
        "id": "zZ2rSxCpmFeP"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# chemo\n",
        "pattern = re.compile(r\"\\b(chemo)\\b\", re.IGNORECASE)\n",
        "df1[\"ccat\"]=np.where(df1[\"title\"].str.contains(pattern),\"chemo\" ,\"other\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AC9Af-IYmPyV",
        "outputId": "f0e9a810-16fe-462a-f530-bb0a5c5a783c"
      },
      "execution_count": 53,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-53-fa2eaada8c71>:3: UserWarning: This pattern is interpreted as a regular expression, and has match groups. To actually get the groups, use str.extract.\n",
            "  df1[\"ccat\"]=np.where(df1[\"title\"].str.contains(pattern),\"chemo\" ,\"other\")\n",
            "<ipython-input-53-fa2eaada8c71>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1[\"ccat\"]=np.where(df1[\"title\"].str.contains(pattern),\"chemo\" ,\"other\")\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"ccat\" , y=\"duration\",palette=\"Set2\", data=df1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "NbholbkJnAGB",
        "outputId": "735a9033-cfc8-4ada-c959-111e3c830e51"
      },
      "execution_count": 54,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# immuno\n",
        "pattern = re.compile(r\"\\b(immuno)\\b\", re.IGNORECASE)\n",
        "df1[\"ccat\"]=np.where(df1[\"title\"].str.contains(pattern),\"immuno\" ,\"other\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Eh_X8IzQnJpq",
        "outputId": "30f25110-d5a4-46e4-fbc6-659110257e23"
      },
      "execution_count": 55,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-55-aadf85eef87e>:3: UserWarning: This pattern is interpreted as a regular expression, and has match groups. To actually get the groups, use str.extract.\n",
            "  df1[\"ccat\"]=np.where(df1[\"title\"].str.contains(pattern),\"immuno\" ,\"other\")\n",
            "<ipython-input-55-aadf85eef87e>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1[\"ccat\"]=np.where(df1[\"title\"].str.contains(pattern),\"immuno\" ,\"other\")\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"ccat\" , y=\"duration\",palette=\"Set2\", data=df1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "XdGTHUMenQ75",
        "outputId": "a8bd2557-897a-41a9-9c2b-d5b45a49c0ff"
      },
      "execution_count": 56,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "iVBORw0KGgoAAAANSUhEUgAAAkQAAAGwCAYAAABIC3rIAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/bCgiHAAAACXBIWXMAAA9hAAAPYQGoP6dpAAAmdElEQVR4nO3df1iUdb7/8dcIDD9EfiUw0iKymqYGllRG/iiTI/5Yt8zaUMsy0tUjW0qo61WSubW2bmqWndy2LXWPrrpHc1srkzC1Q6ipUWbmqgcXPfKrVBDdAOE+f/Rlvk6aKTHMyOf5uK65Lue+P3PP+24v9Lkz9ww2y7IsAQAAGKyVpwcAAADwNIIIAAAYjyACAADGI4gAAIDxCCIAAGA8gggAABiPIAIAAMbz9fQAV4L6+nodO3ZMbdq0kc1m8/Q4AADgEliWpVOnTikmJkatWl38NSCC6BIcO3ZMsbGxnh4DAAA0wpEjR/STn/zkomsIokvQpk0bSd/+Bw0JCfHwNAAA4FJUVlYqNjbW+e/4xRBEl6DhbbKQkBCCCACAK8ylXO7CRdUAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIzn6+kBAMAEZa9M8/QIgFeKmjjX0yNI4hUiAAAAgggAAIAgAgAAxiOIAACA8QgiAABgPIIIAAAYjyACAADGI4gAAIDxCCIAAGA8gggAABiPIAIAAMYjiAAAgPEIIgAAYDyCCAAAGI8gAgAAxiOIAACA8QgiAABgPIIIAAAYjyACAADGI4gAAIDxCCIAAGA8gggAABiPIAIAAMYjiAAAgPEIIgAAYDyPBtGcOXN00003qU2bNoqKitJdd92l/fv3u6z55ptvNGnSJF111VUKDg7WiBEjVFpa6rKmqKhIQ4cOVVBQkKKiojR16lSdPXvWZc3mzZvVs2dP+fv7q1OnTlqyZIm7Tw8AAFwhPBpEW7Zs0aRJk7Rt2zbl5OSotrZWAwcO1OnTp51rpkyZor///e/661//qi1btujYsWO6++67nfvr6uo0dOhQ1dTU6KOPPtLSpUu1ZMkSZWdnO9cUFhZq6NCh6t+/vwoKCjR58mQ98sgjeu+995r1fAEAgHeyWZZleXqIBuXl5YqKitKWLVvUr18/VVRUKDIyUitWrNA999wjSfryyy/VtWtX5efn65ZbbtG7776rn/3sZzp27Jiio6MlSYsXL9b06dNVXl4uu92u6dOn6+2339bnn3/ufK60tDSdPHlSGzZs+MG5KisrFRoaqoqKCoWEhLjn5AG0aGWvTPP0CIBXipo4123Hvpx/v73qGqKKigpJUkREhCRp165dqq2tVUpKinPNtddeq/bt2ys/P1+SlJ+fr4SEBGcMSVJqaqoqKyu1d+9e55pzj9GwpuEY31VdXa3KykqXGwAAaLm8Jojq6+s1efJk9e7dW9ddd50kqaSkRHa7XWFhYS5ro6OjVVJS4lxzbgw17G/Yd7E1lZWV+te//nXeLHPmzFFoaKjzFhsb2yTnCAAAvJPXBNGkSZP0+eefa+XKlZ4eRTNmzFBFRYXzduTIEU+PBAAA3MjX0wNIUkZGhtavX6+tW7fqJz/5iXO7w+FQTU2NTp486fIqUWlpqRwOh3PNjh07XI7X8Cm0c9d895NppaWlCgkJUWBg4Hnz+Pv7y9/fv0nODQAAeD+PvkJkWZYyMjL05ptvatOmTYqPj3fZn5SUJD8/P+Xm5jq37d+/X0VFRUpOTpYkJScna8+ePSorK3OuycnJUUhIiLp16+Zcc+4xGtY0HAMAAJjNo68QTZo0SStWrNDf/vY3tWnTxnnNT2hoqAIDAxUaGqr09HRlZmYqIiJCISEh+tWvfqXk5GTdcsstkqSBAweqW7dueuCBBzR37lyVlJToySef1KRJk5yv8kyYMEGLFi3StGnT9PDDD2vTpk1avXq13n77bY+dOwAA8B4efYXolVdeUUVFhW6//Xa1a9fOeVu1apVzzYIFC/Szn/1MI0aMUL9+/eRwOLR27Vrnfh8fH61fv14+Pj5KTk7W/fffrzFjxmj27NnONfHx8Xr77beVk5OjHj16aN68eXrttdeUmprarOcLAAC8k1d9D5G34nuIAPxYfA8RcGF8DxEAAICXIIgAAIDxCCIAAGA8gggAABiPIAIAAMYjiAAAgPEIIgAAYDyCCAAAGI8gAgAAxiOIAACA8QgiAABgPIIIAAAYjyACAADGI4gAAIDxfD09AOBNHnvsMZWXl0uSIiMjtXDhQg9PBABoDgQRcI7y8nKVlpZ6egwAQDPjLTMAAGA8gggAABiPIAIAAMYjiAAAgPEIIgAAYDyCCAAAGI8gAgAAxiOIAACA8QgiAABgPIIIAAAYjyACAADG43eZeZHH313m6RGMd/xfVS5/5n8T7zBv8BhPjwCgheMVIgAAYDyCCAAAGI8gAgAAxiOIAACA8QgiAABgPIIIAAAYjyACAADGI4gAAIDxCCIAAGA8gggAABiPX90BnMPepvUF/wwAaNkIIuAc14wc7OkRAAAewFtmAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADCeR4No69atGjZsmGJiYmSz2bRu3TqX/Q899JBsNpvLbdCgQS5rjh8/rtGjRyskJERhYWFKT09XVVWVy5rPPvtMffv2VUBAgGJjYzV37lx3nxoAALiCeDSITp8+rR49eujll1/+3jWDBg1ScXGx8/aXv/zFZf/o0aO1d+9e5eTkaP369dq6davGjx/v3F9ZWamBAwcqLi5Ou3bt0u9//3vNmjVLr776qtvOCwAAXFl8PfnkgwcP1uDBgy+6xt/fXw6H44L79u3bpw0bNujjjz/WjTfeKEl66aWXNGTIED3//POKiYnR8uXLVVNTo9dff112u13du3dXQUGB5s+f7xJO56qurlZ1dbXzfmVlZSPPEAAAXAm8/hqizZs3KyoqSl26dNHEiRP19ddfO/fl5+crLCzMGUOSlJKSolatWmn79u3ONf369ZPdbneuSU1N1f79+3XixIkLPuecOXMUGhrqvMXGxrrp7AAAgDfw6iAaNGiQli1bptzcXP3ud7/Tli1bNHjwYNXV1UmSSkpKFBUV5fIYX19fRUREqKSkxLkmOjraZU3D/YY13zVjxgxVVFQ4b0eOHGnqUwMAAF7Eo2+Z/ZC0tDTnnxMSEpSYmKiOHTtq8+bNGjBggNue19/fX/7+/m47PgAA8C5e/QrRd/30pz9V27ZtdfDgQUmSw+FQWVmZy5qzZ8/q+PHjzuuOHA6HSktLXdY03P++a5MAAIBZrqggOnr0qL7++mu1a9dOkpScnKyTJ09q165dzjWbNm1SfX29evXq5VyzdetW1dbWOtfk5OSoS5cuCg8Pb94TAAAAXsmjQVRVVaWCggIVFBRIkgoLC1VQUKCioiJVVVVp6tSp2rZtmw4fPqzc3Fzdeeed6tSpk1JTUyVJXbt21aBBgzRu3Djt2LFDeXl5ysjIUFpammJiYiRJo0aNkt1uV3p6uvbu3atVq1Zp4cKFyszM9NRpAwAAL+PRINq5c6duuOEG3XDDDZKkzMxM3XDDDcrOzpaPj48+++wz/fznP1fnzp2Vnp6upKQkffjhhy7X9yxfvlzXXnutBgwYoCFDhqhPnz4u3zEUGhqqjRs3qrCwUElJSXr88ceVnZ39vR+5BwAA5vHoRdW33367LMv63v3vvffeDx4jIiJCK1asuOiaxMREffjhh5c9HwAAMMMVdQ0RAACAOxBEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMJ5vYx944MABffDBByorK1N9fb3Lvuzs7B89GAAAQHNpVBD98Y9/1MSJE9W2bVs5HA7ZbDbnPpvNRhABAIArSqOC6JlnntGzzz6r6dOnN/U8AAAAza5R1xCdOHFC9957b1PPAgAA4BGNCqJ7771XGzdubOpZAAAAPKJRb5l16tRJM2fO1LZt25SQkCA/Pz+X/Y8++miTDAcAANAcGhVEr776qoKDg7VlyxZt2bLFZZ/NZiOIAADAFaVRQVRYWNjUcwAAAHjMj/5iRsuyZFlWU8wCAADgEY0OomXLlikhIUGBgYEKDAxUYmKi/vznPzflbAAAAM2iUW+ZzZ8/XzNnzlRGRoZ69+4tSfrv//5vTZgwQV999ZWmTJnSpEMCAAC4U6OC6KWXXtIrr7yiMWPGOLf9/Oc/V/fu3TVr1iyCCAAAXFEa9ZZZcXGxbr311vO233rrrSouLv7RQwEAADSnRgVRp06dtHr16vO2r1q1Stdcc82PHgoAAKA5Neots6efflr33Xeftm7d6ryGKC8vT7m5uRcMJQAAAG/WqFeIRowYoe3bt6tt27Zat26d1q1bp7Zt22rHjh0aPnx4U88IAADgVo16hUiSkpKS9J//+Z9NOQsAAIBHXHIQVVZWKiQkxPnni2lYBwAAcCW45CAKDw9XcXGxoqKiFBYWJpvNdt4ay7Jks9lUV1fXpEMCAAC40yUH0aZNmxQRESFJ+uCDD9w2EAAAQHO75CC67bbbnH+Oj49XbGzsea8SWZalI0eONN10AAAAzaBRnzKLj49XeXn5eduPHz+u+Pj4Hz0UAABAc2pUEDVcK/RdVVVVCggI+NFDAQAANKfL+th9ZmamJMlms2nmzJkKCgpy7qurq9P27dt1/fXXN+mAAAAA7nZZQfTJJ59I+vYVoj179shutzv32e129ejRQ1lZWU07IQAAgJtdVhA1fLps7NixWrhwId83BAAAWoRGfVP1G2+80dRzAAAAeEyjf3XHzp07tXr1ahUVFammpsZl39q1a3/0YAAAAM2lUZ8yW7lypW699Vbt27dPb775pmpra7V3715t2rRJoaGhTT0jAACAWzUqiH77299qwYIF+vvf/y673a6FCxfqyy+/1C9+8Qu1b9++qWcEAABwq0YF0aFDhzR06FBJ33667PTp07LZbJoyZYpeffXVJh0QAADA3RoVROHh4Tp16pQk6eqrr9bnn38uSTp58qTOnDnTdNMBAAA0g0ZdVN2vXz/l5OQoISFB9957rx577DFt2rRJOTk5GjBgQFPPCAAA4FaNCqJFixbpm2++kSQ98cQT8vPz00cffaQRI0boySefbNIBAQAA3O2yg+js2bNav369UlNTJUmtWrXSr3/96yYfDAAAoLlc9jVEvr6+mjBhgvMVIgAAgCtdoy6qvvnmm1VQUNDEowAAAHhGo64h+vd//3dlZmbqyJEjSkpKUuvWrV32JyYmNslwAAAAzaFRQZSWliZJevTRR53bbDabLMuSzWZTXV1d00wHAADQDBoVRIWFhU09BwAAgMc0Koji4uKaeg4AAACPaVQQLVu27KL7x4wZ06hhAAAAPKFRQfTYY4+53K+trdWZM2dkt9sVFBREEAEAgCtKoz52f+LECZdbVVWV9u/frz59+ugvf/lLU88IAADgVo0Kogu55ppr9Nxzz5336hEAAIC3a7Igkr79Futjx4415SEBAADcrlFB9NZbb7nc/va3v2nx4sW6//771bt370s+ztatWzVs2DDFxMTIZrNp3bp1Lvsty1J2drbatWunwMBApaSk6MCBAy5rjh8/rtGjRyskJERhYWFKT09XVVWVy5rPPvtMffv2VUBAgGJjYzV37tzGnDYAAGihGnVR9V133eVy32azKTIyUnfccYfmzZt3ycc5ffq0evTooYcfflh33333efvnzp2rF198UUuXLlV8fLxmzpyp1NRUffHFFwoICJAkjR49WsXFxcrJyVFtba3Gjh2r8ePHa8WKFZKkyspKDRw4UCkpKVq8eLH27Nmjhx9+WGFhYRo/fnxjTh8AALQwjQqi+vr6JnnywYMHa/DgwRfcZ1mWXnjhBT355JO68847JX37cf/o6GitW7dOaWlp2rdvnzZs2KCPP/5YN954oyTppZde0pAhQ/T8888rJiZGy5cvV01NjV5//XXZ7XZ1795dBQUFmj9/PkEEAAAkXUYQZWZmXvJB58+f36hhzlVYWKiSkhKlpKQ4t4WGhqpXr17Kz89XWlqa8vPzFRYW5owhSUpJSVGrVq20fft2DR8+XPn5+erXr5/sdrtzTWpqqn73u9/pxIkTCg8PP++5q6urVV1d7bxfWVn5o88HAAB4r0sOok8++cTl/u7du3X27Fl16dJFkvSPf/xDPj4+SkpKapLBSkpKJEnR0dEu26Ojo537SkpKFBUV5bLf19dXERERLmvi4+PPO0bDvgsF0Zw5c/T00083yXkAAADvd8lB9MEHHzj/PH/+fLVp00ZLly51BsWJEyc0duxY9e3bt+mnbGYzZsxweUWssrJSsbGxHpwIAAC4U6M+ZTZv3jzNmTPH5dWV8PBwPfPMM5d1UfXFOBwOSVJpaanL9tLSUuc+h8OhsrIyl/1nz57V8ePHXdZc6BjnPsd3+fv7KyQkxOUGAABarkYFUWVlpcrLy8/bXl5erlOnTv3ooSQpPj5eDodDubm5Ls+7fft2JScnS5KSk5N18uRJ7dq1y7lm06ZNqq+vV69evZxrtm7dqtraWueanJwcdenS5YJvlwEAAPM0KoiGDx+usWPHau3atTp69KiOHj2qNWvWKD09/YIfn/8+VVVVKigoUEFBgaRvL6QuKChQUVGRbDabJk+erGeeeUZvvfWW9uzZozFjxigmJsb5sf+uXbtq0KBBGjdunHbs2KG8vDxlZGQoLS1NMTExkqRRo0bJbrcrPT1de/fu1apVq7Rw4cLLukgcAAC0bI362P3ixYuVlZWlUaNGOV958fX1VXp6un7/+99f8nF27typ/v37O+83RMqDDz6oJUuWaNq0aTp9+rTGjx+vkydPqk+fPtqwYYPzO4gkafny5crIyNCAAQPUqlUrjRgxQi+++KJzf2hoqDZu3KhJkyYpKSlJbdu2VXZ2Nh+5BwAATjbLsqzGPvj06dM6dOiQJKljx45q3bp1kw3mTSorKxUaGqqKigq3Xk/0+LvL3HZs4Eo2b/AYT4/wo5W9Ms3TIwBeKWqi+357xOX8+92oV4gatG7dWomJiT/mEAAAAB7XpL/cFQAA4EpEEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACM59VBNGvWLNlsNpfbtdde69z/zTffaNKkSbrqqqsUHBysESNGqLS01OUYRUVFGjp0qIKCghQVFaWpU6fq7NmzzX0qAADAi/l6eoAf0r17d73//vvO+76+/3/kKVOm6O2339Zf//pXhYaGKiMjQ3fffbfy8vIkSXV1dRo6dKgcDoc++ugjFRcXa8yYMfLz89Nvf/vbZj8XAADgnbw+iHx9feVwOM7bXlFRoT/96U9asWKF7rjjDknSG2+8oa5du2rbtm265ZZbtHHjRn3xxRd6//33FR0dreuvv16/+c1vNH36dM2aNUt2u/2Cz1ldXa3q6mrn/crKSvecHAAA8Ape/ZaZJB04cEAxMTH66U9/qtGjR6uoqEiStGvXLtXW1iolJcW59tprr1X79u2Vn58vScrPz1dCQoKio6Oda1JTU1VZWam9e/d+73POmTNHoaGhzltsbKybzg4AAHgDrw6iXr16acmSJdqwYYNeeeUVFRYWqm/fvjp16pRKSkpkt9sVFhbm8pjo6GiVlJRIkkpKSlxiqGF/w77vM2PGDFVUVDhvR44cadoTAwAAXsWr3zIbPHiw88+JiYnq1auX4uLitHr1agUGBrrtef39/eXv7++24wMAAO/i1a8QfVdYWJg6d+6sgwcPyuFwqKamRidPnnRZU1pa6rzmyOFwnPeps4b7F7ouCQAAmOmKCqKqqiodOnRI7dq1U1JSkvz8/JSbm+vcv3//fhUVFSk5OVmSlJycrD179qisrMy5JicnRyEhIerWrVuzzw8AALyTV79llpWVpWHDhikuLk7Hjh3TU089JR8fH40cOVKhoaFKT09XZmamIiIiFBISol/96ldKTk7WLbfcIkkaOHCgunXrpgceeEBz585VSUmJnnzySU2aNIm3xAAAgJNXB9HRo0c1cuRIff3114qMjFSfPn20bds2RUZGSpIWLFigVq1aacSIEaqurlZqaqr+4z/+w/l4Hx8frV+/XhMnTlRycrJat26tBx98ULNnz/bUKQEAAC/k1UG0cuXKi+4PCAjQyy+/rJdffvl718TFxemdd95p6tEAAEALckVdQwQAAOAOBBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABAADjEUQAAMB4BBEAADAeQQQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeEYF0csvv6wOHTooICBAvXr10o4dOzw9EgAA8ALGBNGqVauUmZmpp556Srt371aPHj2UmpqqsrIyT48GAAA8zJggmj9/vsaNG6exY8eqW7duWrx4sYKCgvT66697ejQAAOBhvp4eoDnU1NRo165dmjFjhnNbq1atlJKSovz8/PPWV1dXq7q62nm/oqJCklRZWenWOavP/MutxweuVO7+2WsOp/5V/cOLAAMFuPHnu+HvDsuyfnCtEUH01Vdfqa6uTtHR0S7bo6Oj9eWXX563fs6cOXr66afP2x4bG+u2GQF8v5c1wdMjAHCXx190+1OcOnVKoaGhF11jRBBdrhkzZigzM9N5v76+XsePH9dVV10lm83mwcnQHCorKxUbG6sjR44oJCTE0+MAaEL8fJvFsiydOnVKMTExP7jWiCBq27atfHx8VFpa6rK9tLRUDofjvPX+/v7y9/d32RYWFubOEeGFQkJC+AsTaKH4+TbHD70y1MCIi6rtdruSkpKUm5vr3FZfX6/c3FwlJyd7cDIAAOANjHiFSJIyMzP14IMP6sYbb9TNN9+sF154QadPn9bYsWM9PRoAAPAwY4LovvvuU3l5ubKzs1VSUqLrr79eGzZsOO9Ca8Df319PPfXUeW+bArjy8fON72OzLuWzaAAAAC2YEdcQAQAAXAxBBAAAjEcQAQAA4xFEwP9z++23a/LkyZ4eAzASP3/wNGM+ZQY02Lx5s/r3768TJ07whZuAl1i7dq38/Pw8PQYMRhABblRTUyO73e7pMQCvFxER4ekRYDjeMkOLVF1drUcffVRRUVEKCAhQnz599PHHH+vw4cPq37+/JCk8PFw2m00PPfSQ83H19fWaNm2aIiIi5HA4NGvWLJfjnjx5Uo888ogiIyMVEhKiO+64Q59++qlz/6xZs3T99dfrtddeU3x8vAICAprjdIEr3rlvmXXo0EHPPPOMxowZo+DgYMXFxemtt95SeXm57rzzTgUHBysxMVE7d+50Pn7JkiUKCwvT+vXr1aVLFwUFBemee+7RmTNntHTpUnXo0EHh4eF69NFHVVdX53yczWbTunXrXGYJCwvTkiVLJEmHDx+WzWbT2rVr1b9/fwUFBalHjx7Kz893ecyaNWvUvXt3+fv7q0OHDpo3b55b/jvBfQgitEjTpk3TmjVrtHTpUu3evVudOnVSamqq2rRpozVr1kiS9u/fr+LiYi1cuND5uKVLl6p169bavn275s6dq9mzZysnJ8e5/95771VZWZneffdd7dq1Sz179tSAAQN0/Phx55qDBw9qzZo1Wrt2rQoKCprtnIGWZMGCBerdu7c++eQTDR06VA888IDGjBmj+++/X7t371bHjh01ZswYnftVemfOnNGLL76olStXasOGDdq8ebOGDx+ud955R++8847+/Oc/6w9/+IP+67/+67LneeKJJ5SVlaWCggJ17txZI0eO1NmzZyVJu3bt0i9+8QulpaVpz549mjVrlmbOnOmMKlwhLKCFqaqqsvz8/Kzly5c7t9XU1FgxMTHW3LlzrQ8++MCSZJ04ccLlcbfddpvVp08fl2033XSTNX36dMuyLOvDDz+0QkJCrG+++cZlTceOHa0//OEPlmVZ1lNPPWX5+flZZWVlbjgzoOW67bbbrMcee8yyLMuKi4uz7r//fue+4uJiS5I1c+ZM57b8/HxLklVcXGxZlmW98cYbliTr4MGDzjW//OUvraCgIOvUqVPObampqdYvf/lL531J1ptvvukyS2hoqPXGG29YlmVZhYWFliTrtddec+7fu3evJcnat2+fZVmWNWrUKOvf/u3fXI4xdepUq1u3bo34LwFP4RUitDiHDh1SbW2tevfu7dzm5+enm2++Wfv27bvoYxMTE13ut2vXTmVlZZKkTz/9VFVVVbrqqqsUHBzsvBUWFurQoUPOx8TFxSkyMrIJzwgwz7k/iw2/YikhIeG8bQ0/n5IUFBSkjh07uqzp0KGDgoODXbad+5jGzNOuXTuX5963b5/L3zeS1Lt3bx04cMDl7Tl4Ny6qBs7x3U+52Gw21dfXS5KqqqrUrl07bd68+bzHnftptdatW7tzRMAI5/4s2my2793W8PP53f0Nay72M91w3/rOb7Cqra29pHnOPQ6ufAQRWpyOHTvKbrcrLy9PcXFxkr79C+7jjz/W5MmTnZ/6utz/59azZ0+VlJTI19dXHTp0aOqxAXhAZGSkiouLnfcPHDigM2fOXNYxunbtqry8PJdteXl56ty5s3x8fJpkTrgfb5mhxWndurUmTpyoqVOnasOGDfriiy80btw4nTlzRunp6YqLi5PNZtP69etVXl6uqqqqSzpuSkqKkpOTddddd2njxo06fPiwPvroIz3xxBMun3YBcOW44447tGjRIn3yySfauXOnJkyYcNnfh/T4448rNzdXv/nNb/SPf/xDS5cu1aJFi5SVleWmqeEOBBFapOeee04jRozQAw88oJ49e+rgwYN67733FB4erquvvlpPP/20fv3rXys6OloZGRmXdEybzaZ33nlH/fr109ixY9W5c2elpaXpn//8p/N6BgBXlnnz5ik2NlZ9+/bVqFGjlJWVpaCgoMs6Rs+ePbV69WqtXLlS1113nbKzszV79myXr/SA97NZ333zFAAAwDC8QgQAAIxHEAEAAOMRRAAAwHgEEQAAMB5BBAAAjEcQAQAA4xFEAADAeAQRAAAwHkEEAACMRxABwCXq0KGDXnjhBU+PAcANCCIAAGA8gghAi1JfX6+5c+eqU6dO8vf3V/v27fXss89Kko4ePaqRI0cqIiJCrVu31o033qjt27dLkg4dOqQ777xT0dHRCg4O1k033aT333/fedzbb79d//znPzVlyhTZbDbZbDaPnB8A9/D19AAA0JRmzJihP/7xj1qwYIH69Omj4uJiffnll6qqqtJtt92mq6++Wm+99ZYcDod2796t+vp6SVJVVZWGDBmiZ599Vv7+/lq2bJmGDRum/fv3q3379lq7dq169Oih8ePHa9y4cR4+SwBNjd92D6DFOHXqlCIjI7Vo0SI98sgjLvteffVVZWVl6fDhw4qIiLik41133XWaMGGCMjIyJH17DdHkyZM1efLkph4dgIfxlhmAFmPfvn2qrq7WgAEDzttXUFCgG2644XtjqKqqSllZWeratavCwsIUHBysffv2qaioyN1jA/ACvGUGoMUIDAxs1D5JysrKUk5Ojp5//nl16tRJgYGBuueee1RTU9PUYwLwQrxCBKDFuOaaaxQYGKjc3Nzz9iUmJqqgoEDHjx+/4GPz8vL00EMPafjw4UpISJDD4dDhw4dd1tjtdtXV1bljdAAeRhABaDECAgI0ffp0TZs2TcuWLdOhQ4e0bds2/elPf9LIkSPlcDh01113KS8vT//zP/+jNWvWKD8/X9K3MbV27VoVFBTo008/1ahRo5wXXDfo0KGDtm7dqv/93//VV1995YlTBOAmBBGAFmXmzJl6/PHHlZ2dra5du+q+++5TWVmZ7Ha7Nm7cqKioKA0ZMkQJCQl67rnn5OPjI0maP3++wsPDdeutt2rYsGFKTU1Vz549XY49e/ZsHT58WB07dlRkZKQnTg+Am/ApMwAAYDxeIQIAAMYjiAAAgPEIIgAAYDyCCAAAGI8gAgAAxiOIAACA8QgiAABgPIIIAAAYjyACAADGI4gAAIDxCCIAAGC8/wNEtFtTJdQaRAAAAABJRU5ErkJggg==\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Intervention\n",
        "1. Rituximab\n",
        "2. Other"
      ],
      "metadata": {
        "id": "ZXTCapzBne5J"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# rituximab\n",
        "pattern = re.compile(r\"\\b(rituximab)\\b\", re.IGNORECASE)\n",
        "df1[\"icat\"]=np.where(df1[\"interventions\"].str.contains(pattern),\"ritu\" ,\"other\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_BbwQOPqnWPM",
        "outputId": "51cb50f3-c010-42d7-f030-0008c61d16a7"
      },
      "execution_count": 58,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-58-74df9e2e2109>:3: UserWarning: This pattern is interpreted as a regular expression, and has match groups. To actually get the groups, use str.extract.\n",
            "  df1[\"icat\"]=np.where(df1[\"interventions\"].str.contains(pattern),\"ritu\" ,\"other\")\n",
            "<ipython-input-58-74df9e2e2109>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df1[\"icat\"]=np.where(df1[\"interventions\"].str.contains(pattern),\"ritu\" ,\"other\")\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"icat\" , y=\"duration\",palette=\"Set2\", data=df1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "Lh3yuBown5ZS",
        "outputId": "bbcf7fa6-fdb2-40c6-b059-8eef2569abbe"
      },
      "execution_count": 59,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install openai"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RKE9jQiEfiT5",
        "outputId": "da7e77f0-5f43-419d-d81c-ad8856174d0d"
      },
      "execution_count": 22,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting openai\n",
            "  Downloading openai-0.27.8-py3-none-any.whl (73 kB)\n",
            "\u001b[?25l     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m0.0/73.6 kB\u001b[0m \u001b[31m?\u001b[0m eta \u001b[36m-:--:--\u001b[0m\r\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m73.6/73.6 kB\u001b[0m \u001b[31m4.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: requests>=2.20 in /usr/local/lib/python3.10/dist-packages (from openai) (2.27.1)\n",
            "Requirement already satisfied: tqdm in /usr/local/lib/python3.10/dist-packages (from openai) (4.65.0)\n",
            "Requirement already satisfied: aiohttp in /usr/local/lib/python3.10/dist-packages (from openai) (3.8.4)\n",
            "Requirement already satisfied: urllib3<1.27,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests>=2.20->openai) (1.26.16)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests>=2.20->openai) (2023.5.7)\n",
            "Requirement already satisfied: charset-normalizer~=2.0.0 in /usr/local/lib/python3.10/dist-packages (from requests>=2.20->openai) (2.0.12)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests>=2.20->openai) (3.4)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.10/dist-packages (from aiohttp->openai) (23.1.0)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.10/dist-packages (from aiohttp->openai) (6.0.4)\n",
            "Requirement already satisfied: async-timeout<5.0,>=4.0.0a3 in /usr/local/lib/python3.10/dist-packages (from aiohttp->openai) (4.0.2)\n",
            "Requirement already satisfied: yarl<2.0,>=1.0 in /usr/local/lib/python3.10/dist-packages (from aiohttp->openai) (1.9.2)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.10/dist-packages (from aiohttp->openai) (1.3.3)\n",
            "Requirement already satisfied: aiosignal>=1.1.2 in /usr/local/lib/python3.10/dist-packages (from aiohttp->openai) (1.3.1)\n",
            "Installing collected packages: openai\n",
            "Successfully installed openai-0.27.8\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "import uuid\n",
        "import time\n",
        "import os\n",
        "import openai\n",
        "openai.api_key = \"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\"\n",
        "model_list = openai.Model.list()"
      ],
      "metadata": {
        "id": "E7m6Ycdyfd-l"
      },
      "execution_count": 23,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "pd.set_option(\"max_colwidth\", 500)\n",
        "dff1= df[['outcome measures','duration']]\n",
        "dff1.columns = dff1.columns.str.replace(\" \",\"_\")\n",
        "dff1['outcome_measures']=dff1['outcome_measures'].str.lower()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "05BXpbKofnOK",
        "outputId": "ef2bc34d-1d80-48ba-d525-a07be4474b98"
      },
      "execution_count": 36,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-36-758480ef698d>:4: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  dff1['outcome_measures']=dff1['outcome_measures'].str.lower()\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "group_size = 60\n",
        "#train_df = pd.concat([df[df.target==1].sample(group_size), df[df.target==0].sample(group_size)]).reset_index(drop=True)\n",
        "train_df=dff1[:900]\n",
        "train_df.sample(50)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "m8WuiCdggTZg",
        "outputId": "3bda5238-9c68-4f0e-ac31-7c406c95637b"
      },
      "execution_count": 37,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        outcome_measures  \\\n",
              "364  maximum tolerable dose (mtd) of bortezomib in combination with azacitidine|specific toxicities and the dose limiting toxicity (dlt) of bortezomib in combination with azacitidine as assessed by nci ctcae (common toxicity criteria for adverse effects) v4.0|overall response rate|correlation of the biological activity of azacitidine as a demethylating agent with clinical endpoints and plasma pharmacokinetics|biological activity of bortezomib as a potential demethylating agent|correlation of intr...   \n",
              "6                                                                                                                                                                                             number of participants reporting treatment-emergent adverse events|maximum observed plasma concentration (cmax) of duvelisib|time to maximum observed concentration (tmax) of duvelisib|area under the plasma concentration-time curve (auc) of duvelisib|overall response rate|overall survival|progression free survival   \n",
              "235  phase i stage i: percentage of participants with adverse events and serious adverse events|phase 1 stage 1: percentage of participants with dose-limiting toxicities|phase i stage 1: maximum tolerated dose of gdc-0032|phase i: area under the concentration-time curve (auc) from zero to infinity of gdc-0032|phase i: auc from zero to tau (auctau) of gdc-0032|phase i: maximum observed concentration (cmax) of gdc-0032|phase i: minimum observed concentration (cmin) of gdc-0032|phase i: time to reac...   \n",
              "580                                                                                                                                                                                                                                                                                                                        toxicity graded using the nci ctcae version 3.0|complete and partial response rate according to the international workshop criteria|duration of response|overall survival|time to progression   \n",
              "427  maximum tolerated dose of the combination of romidepsin and carfilzomib|best overall response rate (pr + cr) at the mtd|toxicity of the combination of romidepsin and carfilzomib|best overall response at the mtd|maximum percentage change in the radiological sum of the product of the diameters from baseline, assessed using the revised response criteria for malignant lymphoma|duration of response from time of first documented response until relapse or progression|progression free survival|overa...   \n",
              "735  time to reach maximum observed plasma concentration (tmax)|maximum observed plasma concentration (cmax)|area under the plasma concentratio-time curve from time 0 to the time of the last measurable concentration (auclast)|area under the concentration-time curve from time 0 to infinity (aucinf)|percentage of aucinf based on extrapolation (aucextrap)|observed elimination rate constant associated with the terminal portion of the curve (λ z)|observed terminal elimination half-life (t1/2)|time of ...   \n",
              "249                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NaN   \n",
              "50                                                                                                                                                                                                                                                                                                  maximally tolerated dose (mtd)|number of participants with dose limiting toxicities (dlt)|overall response rate (orr)|median duration of response|median progression free survival (pfs)|median time to next therapy   \n",
              "115  number of participants with treatment-emergent adverse events (aes) and serious adverse events (saes)|number of participants with grade 3 or higher grades treatment-emergent adverse events (teaes) based on severity|maximum tolerated dose (mtd): part 1 (dose escalation cohorts)|number of participants with dose-limiting toxicity (dlt)|progression-free survival (pfs): evaluable population- part 2 (lead-in + expanded cohorts)|progression-free survival (pfs): intent-to-treat population-part 2 (le...   \n",
              "821                                                                                                                                                                                                                                                                                                                         number of participants with treatment emergent adverse events (aes)|food effect cohort assessments|progression free survival rate at 24 months|percentage of participants achieving response   \n",
              "349                                                                                                                                                                                                                       overall response rate as assessed according to the\"revised response criteria for malignant lymphoma\" (cheson 2007).|clinical benefit rate as assessed according to the \"revised response criteria for malignant lymphoma\" (cheson 2007).|progression free survival (pfs)|overall survival (os)   \n",
              "895                                                                                                                                                                                                                                                                                     safety and tolerability of cdx-1140 as assessed by ctcae v5.0|objective response rate|clinical benefit rate|duration of response|progression-free survival|overall survival|immunogenicity evaluation|pharmacokinetic evaluation   \n",
              "435                                                                             mtd defined as the dose level at which no more than one of 6 patients experiences a dlt summarized using the national cancer institute (nci) ctcae version 4.0|incidence of grade 3 or greater adverse events summarized using the nci ctcae version 4.0|overall response rate (orr) evaluated by computed tomography (ct) or positron emission tomography (pet)/ct|change in correlative markers in blood, bone marrow and tumor tissue   \n",
              "430                                                                  dose limiting toxicity (dlt) rate by the nci common toxicity criteria (ctcae) v2.0 and the method of przepiorka et al (protocol appendix i)|response rate according to the harmonization project (protocol 8.5.1) or recist criteria.|grade iii-iv toxicity rate in participants receiving an extended dosage regimen according to the nci common toxicity criteria (ctcae) version 2.0 and the method of przepiorka et. al. (protocol appendix i).   \n",
              "68                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   NaN   \n",
              "116                                                                                                                                                                                                                                                                                                                                                                                                                              safety and tolerability profile|objective response rate (orr)|tumor response assessment   \n",
              "833  to assess safety of parathyroid hormone in combination with g-csf when used as a mobilization agent at four different dosing levels.|to evaluate the peripheral blood cd34+ count after second mobilization.|to evaluate cd34+ cells/kg from apheresis after second mobilization.|to evaluate the percent of patients for whom adequate numbers of cd34+ cells are obtained.|to evaluate transfusion support.|to evaluate the days to neutrophil engraftment (anc >500) post autologous transplant.|to evaluate ...   \n",
              "15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   NaN   \n",
              "863                                                                                                                                                                                     clinically significant or > or = to grade 3 ctcae changes in safety laboratory tests, physical exams, ecgs or vital signs|pk parameters|clinical/radiological response rate for cll subjects|treatment-emergent adverse events|phospho-akt level in circulating cll cells|number of patients with clinical/radiological response   \n",
              "45   feasibility (generation of autologous clinical grade ade1-lmp-specific ctl from the blood of ebv-positive lymphoma patients)|safety as assessed by adverse event monitoring. patients will be questioned and toxicities recorded according to the international common toxicity criteria.|reconstitution of ebv-specific ctl immunity with anti-viral efficacy measured by immunological & virological assessment of blood samples including immunophenotyping, intracellular cytokine assays, cd107 cytotoxicit...   \n",
              "671                                                                                                                                              phase i: the maximum tolerated dose (mtd) of temsirolimus in combination with bortezomib, rituximab and dexamethasone|phase ii: progression-free survival|phase ii: time to progression|phase ii: major response rate|phase ii: minor response rate|phase ii: time to response|phase ii: duration of response|phase ii: time to next therapy|phase ii: overall survival   \n",
              "686                                                                                                                                                                                                                                                                                                                                                                               adverse events|percentage of participants who have received some form of response|pk-cmax|pk-tmax|pk-λz|pk-t1/2|pk-auc (0-t)|pk-auc0-∞   \n",
              "858                                                                                                                                                                                                                                                                                                                                                                                      objective responses assessed by international workshop criteria (iwc)|duration of response|progression-free survival (pfs) time   \n",
              "834  safety, tolerability, maximum tolerated dose (mtd), and dose-limiting toxicity of oral administration of xl184|evaluate plasma pharmacokinetics and estimate renal elimination of oral administration of xl184|long-term safety/tolerability of xl184 after oral administration for up to 1 year|evaluate preliminary tumor response after repeated xl184 administration|in mtd expanded cohort: progression-free survival and duration of response in subjects with advanced or recurrent medullary thyroid cancer   \n",
              "581                                                                                                                                                                                                                          mtd of photodynamic therapy|mtd of silicon phthalocyanine 4 defined as the dose immediately below the dose in which 2 or more of 6 patients experience a grade 4 toxicity assessed using national cancer institute (nci) common terminology criteria for adverse events (ctcae) version 4.0   \n",
              "417                                                                                                                    phase i part: determination of the recommended dose of lenalidomide in combination with fixed doses of ga101|phase ii part: overall response rate (cr+cru+pr) after 6 cycles|overall survival (os)|event free survival|progression free survival|response duration|response rate at the end of maintenance treatment|complete response rate after induction|complete response rate after 3 cycles   \n",
              "808                                                                                                                                                                                                                                                                                                                         to determine the effect of rifampin on the pharmacokinetics of navitoclax.|to determine the safety of navitoclax when administered alone and in combination with rifampin in these patients.   \n",
              "253                                                                                                                                                                                                                                                                                                                                                                                       dose limiting toxicity assessment for each patient.|adverse events|pharmacokinetic/ pharmacodynamic assessments|tumor response   \n",
              "131  incidence and severity of aes and saes, incl. changes in laboratory parameters, vital signs and ecgs.|incidence of dlts during the first cycle of treatment with single agent mik665 during the dose escalation phase only|tolerability: dose interruptions|tolerability: dose reductions|tolerability: dose intensity|best overall response (bor) per international myeloma working group (imwg) criteria for myeloma; and per revised criteria for staging of the international working group (iwg) guidelines...   \n",
              "268                                                                                                                                                                                                                                                                                                                                                                             incidence and nature of dose-limiting toxicities (dlts)|objective response, defined as a partial response (pr) or complete response (cr)   \n",
              "633                                                                                          number of phase i participants with dose-limiting toxicity events (phase i)|proportion of complete response defined to be a cr or cri noted as the objective status (phase ii)|biomarker analysis (igvh gene mutation)|biomarker analysis (cd38, cd49d, and zap-70)|fluorescent in situ hybridization (fish) biomarker analysis|duration of response|minimal-residual disease|overall response rate|treatment-free survival   \n",
              "294  duration of exposure to idela|toxicity of administration of idela|overall response rate|duration of response|time to response|progression-free survival|overall survival|plasma concentration of idela (cohort 1, cohorts 2 and 3, cohort 5)|plasma concentration of idela (cohort 4)|plasma concentration of idela (cohort 6)|plasma concentration of idela (cohort 7)|sub-study: plasma concentration of idela (cohorts 1-4)|plasma concentration of bendamustine|plasma concentration of everolimus|plasma co...   \n",
              "103                                                                                                                                                                                                                                                                                                                                                                                        determine the maximum tolerated dose (mtd) of ezn-2968.|determine the pharmacokinetic (pk) profile; determine the pd profile.   \n",
              "292  the maximum tolerated dose of plerixafor when combined with rituximab as treatment for previously treated patients with chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll)|the principal toxicities and dose limiting toxicities of plerixafor when combined with rituximab|time to maximal plasma concentration (tmax) when plerixafor is combined with rituximab|area under the concentration-time curve from time zero to the last observed concentration (auc 0-last) when plerixafor is...   \n",
              "125                                                                                                                                                                                                                                                                                                                                                   number of participants experiencing dose limiting toxicity (dlt) during combination treatment|number and frequency of adverse events|objective response rate (orr)   \n",
              "521                                                                                                                                                                                                                                                                                                                            define the mtd|tumor burden according to response evaluation criteria in solid tumors (recist)/revised response criteria malignant lymphoma|translational biomarkers and pharmacokinetics   \n",
              "595                                                                                                                                                                                                                                                                                                maximum tolerated dose/dose limiting toxicity|overall and progression-free survival rate|response rate|toxicity/tolerability of study regimen|feasibility of concurrent high-dose radioimmunotherapy and chemotherapy   \n",
              "662                                                                                                                                                                                                                                                                                                                                                                                                                                      objective response rate (orr) based on evaluation by image assessment committee   \n",
              "857                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NaN   \n",
              "620                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NaN   \n",
              "592                                                                                                                                                                                                                                                                                                                                                                                                                                        maximum tolerated dose (mtd) assessed by common toxicity criteria version 2.0   \n",
              "791                                                                                                                                                                                                                                                                                                                                                                                                                       occurrence of study related adverse events|anti-tumor responses to tancart19/20 cell infusions   \n",
              "597                                                                                                                                                                                                                                                                                                                                                                                                                                      maximum tolerated dose of idarubicin|remission rate after 4 cycles and 8 cycles   \n",
              "855                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NaN   \n",
              "70                                                                                                                                                                                                                                                  dose-limiting toxicity (dlt)|adverse events|complete response rate|duration of response|progression free survival|objective response rate|overall survival|area under the concentration versus time curve (auc)|peak plasma concentration (cmax)|time of cmax (tmax)   \n",
              "891                                                                                                                                                                                                                                                                           to determine the optimal regimen of post-graft immunosuppression with high-dose cy following fludarabine, busulfan, and transplantation of fully hla-matched bone marrow that leads to an acceptable incidence of grades iii/iv acute gvhd   \n",
              "178                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            pk parameter|pd parameter   \n",
              "653                                                                                             determine rate of dose limiting toxicities|number of participants with dose limiting toxicities to determine maximum tolerated dose.|pharmacokinetics: serum concentration of cpx-351 components (cytarabine and daunorubicin) and metabolites.|tumor measurement by bone marrow biopsy, blood counts, and/or pet/ct scan|serum levels of biomarkers (troponin-1, troponin-t, and b-type natriuretic) of cardiac injury.   \n",
              "242                                                                                           to determine mtd and dlt of gemcitabine oral formulation|ae/sae incidences|changes from baseline in clinical laboratory test (hematology, biochemistry, coagulation factors and urinalysis) results, vital sign measurements, physical examination findings, and ecg and 2d echocardiogram/multiple-gated acquisition (muga) scan results|characterize the pk of d07001-f4|orr(objective response rate) and tumor response   \n",
              "388                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NaN   \n",
              "\n",
              "     duration  \n",
              "364     945.0  \n",
              "6       458.0  \n",
              "235    3754.0  \n",
              "580       NaN  \n",
              "427    2264.0  \n",
              "735     303.0  \n",
              "249       NaN  \n",
              "50     2157.0  \n",
              "115    2679.0  \n",
              "821    1007.0  \n",
              "349    1279.0  \n",
              "895    1747.0  \n",
              "435    1723.0  \n",
              "430    6057.0  \n",
              "68        NaN  \n",
              "116     700.0  \n",
              "833    1004.0  \n",
              "15        NaN  \n",
              "863    2071.0  \n",
              "45     1308.0  \n",
              "671    3696.0  \n",
              "686    2217.0  \n",
              "858    1553.0  \n",
              "834    2495.0  \n",
              "581     760.0  \n",
              "417    3516.0  \n",
              "808     365.0  \n",
              "253    1246.0  \n",
              "131     695.0  \n",
              "268    1612.0  \n",
              "633     884.0  \n",
              "294    1860.0  \n",
              "103    1553.0  \n",
              "292    1187.0  \n",
              "125    1034.0  \n",
              "521    1216.0  \n",
              "595       NaN  \n",
              "662    1576.0  \n",
              "857     457.0  \n",
              "620     943.0  \n",
              "592       NaN  \n",
              "791    1035.0  \n",
              "597    2921.0  \n",
              "855    5113.0  \n",
              "70      880.0  \n",
              "891     944.0  \n",
              "178     758.0  \n",
              "653    2038.0  \n",
              "242    1065.0  \n",
              "388    2496.0  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-2d818e4f-d82c-4634-876b-48ec60c9c114\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>outcome_measures</th>\n",
              "      <th>duration</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>364</th>\n",
              "      <td>maximum tolerable dose (mtd) of bortezomib in combination with azacitidine|specific toxicities and the dose limiting toxicity (dlt) of bortezomib in combination with azacitidine as assessed by nci ctcae (common toxicity criteria for adverse effects) v4.0|overall response rate|correlation of the biological activity of azacitidine as a demethylating agent with clinical endpoints and plasma pharmacokinetics|biological activity of bortezomib as a potential demethylating agent|correlation of intr...</td>\n",
              "      <td>945.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>number of participants reporting treatment-emergent adverse events|maximum observed plasma concentration (cmax) of duvelisib|time to maximum observed concentration (tmax) of duvelisib|area under the plasma concentration-time curve (auc) of duvelisib|overall response rate|overall survival|progression free survival</td>\n",
              "      <td>458.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>235</th>\n",
              "      <td>phase i stage i: percentage of participants with adverse events and serious adverse events|phase 1 stage 1: percentage of participants with dose-limiting toxicities|phase i stage 1: maximum tolerated dose of gdc-0032|phase i: area under the concentration-time curve (auc) from zero to infinity of gdc-0032|phase i: auc from zero to tau (auctau) of gdc-0032|phase i: maximum observed concentration (cmax) of gdc-0032|phase i: minimum observed concentration (cmin) of gdc-0032|phase i: time to reac...</td>\n",
              "      <td>3754.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>580</th>\n",
              "      <td>toxicity graded using the nci ctcae version 3.0|complete and partial response rate according to the international workshop criteria|duration of response|overall survival|time to progression</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>427</th>\n",
              "      <td>maximum tolerated dose of the combination of romidepsin and carfilzomib|best overall response rate (pr + cr) at the mtd|toxicity of the combination of romidepsin and carfilzomib|best overall response at the mtd|maximum percentage change in the radiological sum of the product of the diameters from baseline, assessed using the revised response criteria for malignant lymphoma|duration of response from time of first documented response until relapse or progression|progression free survival|overa...</td>\n",
              "      <td>2264.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>735</th>\n",
              "      <td>time to reach maximum observed plasma concentration (tmax)|maximum observed plasma concentration (cmax)|area under the plasma concentratio-time curve from time 0 to the time of the last measurable concentration (auclast)|area under the concentration-time curve from time 0 to infinity (aucinf)|percentage of aucinf based on extrapolation (aucextrap)|observed elimination rate constant associated with the terminal portion of the curve (λ z)|observed terminal elimination half-life (t1/2)|time of ...</td>\n",
              "      <td>303.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>249</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>50</th>\n",
              "      <td>maximally tolerated dose (mtd)|number of participants with dose limiting toxicities (dlt)|overall response rate (orr)|median duration of response|median progression free survival (pfs)|median time to next therapy</td>\n",
              "      <td>2157.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>115</th>\n",
              "      <td>number of participants with treatment-emergent adverse events (aes) and serious adverse events (saes)|number of participants with grade 3 or higher grades treatment-emergent adverse events (teaes) based on severity|maximum tolerated dose (mtd): part 1 (dose escalation cohorts)|number of participants with dose-limiting toxicity (dlt)|progression-free survival (pfs): evaluable population- part 2 (lead-in + expanded cohorts)|progression-free survival (pfs): intent-to-treat population-part 2 (le...</td>\n",
              "      <td>2679.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>821</th>\n",
              "      <td>number of participants with treatment emergent adverse events (aes)|food effect cohort assessments|progression free survival rate at 24 months|percentage of participants achieving response</td>\n",
              "      <td>1007.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>349</th>\n",
              "      <td>overall response rate as assessed according to the\"revised response criteria for malignant lymphoma\" (cheson 2007).|clinical benefit rate as assessed according to the \"revised response criteria for malignant lymphoma\" (cheson 2007).|progression free survival (pfs)|overall survival (os)</td>\n",
              "      <td>1279.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>895</th>\n",
              "      <td>safety and tolerability of cdx-1140 as assessed by ctcae v5.0|objective response rate|clinical benefit rate|duration of response|progression-free survival|overall survival|immunogenicity evaluation|pharmacokinetic evaluation</td>\n",
              "      <td>1747.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>435</th>\n",
              "      <td>mtd defined as the dose level at which no more than one of 6 patients experiences a dlt summarized using the national cancer institute (nci) ctcae version 4.0|incidence of grade 3 or greater adverse events summarized using the nci ctcae version 4.0|overall response rate (orr) evaluated by computed tomography (ct) or positron emission tomography (pet)/ct|change in correlative markers in blood, bone marrow and tumor tissue</td>\n",
              "      <td>1723.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>430</th>\n",
              "      <td>dose limiting toxicity (dlt) rate by the nci common toxicity criteria (ctcae) v2.0 and the method of przepiorka et al (protocol appendix i)|response rate according to the harmonization project (protocol 8.5.1) or recist criteria.|grade iii-iv toxicity rate in participants receiving an extended dosage regimen according to the nci common toxicity criteria (ctcae) version 2.0 and the method of przepiorka et. al. (protocol appendix i).</td>\n",
              "      <td>6057.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>68</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>116</th>\n",
              "      <td>safety and tolerability profile|objective response rate (orr)|tumor response assessment</td>\n",
              "      <td>700.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>833</th>\n",
              "      <td>to assess safety of parathyroid hormone in combination with g-csf when used as a mobilization agent at four different dosing levels.|to evaluate the peripheral blood cd34+ count after second mobilization.|to evaluate cd34+ cells/kg from apheresis after second mobilization.|to evaluate the percent of patients for whom adequate numbers of cd34+ cells are obtained.|to evaluate transfusion support.|to evaluate the days to neutrophil engraftment (anc &gt;500) post autologous transplant.|to evaluate ...</td>\n",
              "      <td>1004.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>15</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>863</th>\n",
              "      <td>clinically significant or &gt; or = to grade 3 ctcae changes in safety laboratory tests, physical exams, ecgs or vital signs|pk parameters|clinical/radiological response rate for cll subjects|treatment-emergent adverse events|phospho-akt level in circulating cll cells|number of patients with clinical/radiological response</td>\n",
              "      <td>2071.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>45</th>\n",
              "      <td>feasibility (generation of autologous clinical grade ade1-lmp-specific ctl from the blood of ebv-positive lymphoma patients)|safety as assessed by adverse event monitoring. patients will be questioned and toxicities recorded according to the international common toxicity criteria.|reconstitution of ebv-specific ctl immunity with anti-viral efficacy measured by immunological &amp; virological assessment of blood samples including immunophenotyping, intracellular cytokine assays, cd107 cytotoxicit...</td>\n",
              "      <td>1308.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>671</th>\n",
              "      <td>phase i: the maximum tolerated dose (mtd) of temsirolimus in combination with bortezomib, rituximab and dexamethasone|phase ii: progression-free survival|phase ii: time to progression|phase ii: major response rate|phase ii: minor response rate|phase ii: time to response|phase ii: duration of response|phase ii: time to next therapy|phase ii: overall survival</td>\n",
              "      <td>3696.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>686</th>\n",
              "      <td>adverse events|percentage of participants who have received some form of response|pk-cmax|pk-tmax|pk-λz|pk-t1/2|pk-auc (0-t)|pk-auc0-∞</td>\n",
              "      <td>2217.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>858</th>\n",
              "      <td>objective responses assessed by international workshop criteria (iwc)|duration of response|progression-free survival (pfs) time</td>\n",
              "      <td>1553.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>834</th>\n",
              "      <td>safety, tolerability, maximum tolerated dose (mtd), and dose-limiting toxicity of oral administration of xl184|evaluate plasma pharmacokinetics and estimate renal elimination of oral administration of xl184|long-term safety/tolerability of xl184 after oral administration for up to 1 year|evaluate preliminary tumor response after repeated xl184 administration|in mtd expanded cohort: progression-free survival and duration of response in subjects with advanced or recurrent medullary thyroid cancer</td>\n",
              "      <td>2495.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>581</th>\n",
              "      <td>mtd of photodynamic therapy|mtd of silicon phthalocyanine 4 defined as the dose immediately below the dose in which 2 or more of 6 patients experience a grade 4 toxicity assessed using national cancer institute (nci) common terminology criteria for adverse events (ctcae) version 4.0</td>\n",
              "      <td>760.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>417</th>\n",
              "      <td>phase i part: determination of the recommended dose of lenalidomide in combination with fixed doses of ga101|phase ii part: overall response rate (cr+cru+pr) after 6 cycles|overall survival (os)|event free survival|progression free survival|response duration|response rate at the end of maintenance treatment|complete response rate after induction|complete response rate after 3 cycles</td>\n",
              "      <td>3516.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>808</th>\n",
              "      <td>to determine the effect of rifampin on the pharmacokinetics of navitoclax.|to determine the safety of navitoclax when administered alone and in combination with rifampin in these patients.</td>\n",
              "      <td>365.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>253</th>\n",
              "      <td>dose limiting toxicity assessment for each patient.|adverse events|pharmacokinetic/ pharmacodynamic assessments|tumor response</td>\n",
              "      <td>1246.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>131</th>\n",
              "      <td>incidence and severity of aes and saes, incl. changes in laboratory parameters, vital signs and ecgs.|incidence of dlts during the first cycle of treatment with single agent mik665 during the dose escalation phase only|tolerability: dose interruptions|tolerability: dose reductions|tolerability: dose intensity|best overall response (bor) per international myeloma working group (imwg) criteria for myeloma; and per revised criteria for staging of the international working group (iwg) guidelines...</td>\n",
              "      <td>695.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>268</th>\n",
              "      <td>incidence and nature of dose-limiting toxicities (dlts)|objective response, defined as a partial response (pr) or complete response (cr)</td>\n",
              "      <td>1612.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>633</th>\n",
              "      <td>number of phase i participants with dose-limiting toxicity events (phase i)|proportion of complete response defined to be a cr or cri noted as the objective status (phase ii)|biomarker analysis (igvh gene mutation)|biomarker analysis (cd38, cd49d, and zap-70)|fluorescent in situ hybridization (fish) biomarker analysis|duration of response|minimal-residual disease|overall response rate|treatment-free survival</td>\n",
              "      <td>884.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>294</th>\n",
              "      <td>duration of exposure to idela|toxicity of administration of idela|overall response rate|duration of response|time to response|progression-free survival|overall survival|plasma concentration of idela (cohort 1, cohorts 2 and 3, cohort 5)|plasma concentration of idela (cohort 4)|plasma concentration of idela (cohort 6)|plasma concentration of idela (cohort 7)|sub-study: plasma concentration of idela (cohorts 1-4)|plasma concentration of bendamustine|plasma concentration of everolimus|plasma co...</td>\n",
              "      <td>1860.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>103</th>\n",
              "      <td>determine the maximum tolerated dose (mtd) of ezn-2968.|determine the pharmacokinetic (pk) profile; determine the pd profile.</td>\n",
              "      <td>1553.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>292</th>\n",
              "      <td>the maximum tolerated dose of plerixafor when combined with rituximab as treatment for previously treated patients with chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll)|the principal toxicities and dose limiting toxicities of plerixafor when combined with rituximab|time to maximal plasma concentration (tmax) when plerixafor is combined with rituximab|area under the concentration-time curve from time zero to the last observed concentration (auc 0-last) when plerixafor is...</td>\n",
              "      <td>1187.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>125</th>\n",
              "      <td>number of participants experiencing dose limiting toxicity (dlt) during combination treatment|number and frequency of adverse events|objective response rate (orr)</td>\n",
              "      <td>1034.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>521</th>\n",
              "      <td>define the mtd|tumor burden according to response evaluation criteria in solid tumors (recist)/revised response criteria malignant lymphoma|translational biomarkers and pharmacokinetics</td>\n",
              "      <td>1216.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>595</th>\n",
              "      <td>maximum tolerated dose/dose limiting toxicity|overall and progression-free survival rate|response rate|toxicity/tolerability of study regimen|feasibility of concurrent high-dose radioimmunotherapy and chemotherapy</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>662</th>\n",
              "      <td>objective response rate (orr) based on evaluation by image assessment committee</td>\n",
              "      <td>1576.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>857</th>\n",
              "      <td>NaN</td>\n",
              "      <td>457.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>620</th>\n",
              "      <td>NaN</td>\n",
              "      <td>943.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>592</th>\n",
              "      <td>maximum tolerated dose (mtd) assessed by common toxicity criteria version 2.0</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>791</th>\n",
              "      <td>occurrence of study related adverse events|anti-tumor responses to tancart19/20 cell infusions</td>\n",
              "      <td>1035.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>597</th>\n",
              "      <td>maximum tolerated dose of idarubicin|remission rate after 4 cycles and 8 cycles</td>\n",
              "      <td>2921.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>855</th>\n",
              "      <td>NaN</td>\n",
              "      <td>5113.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>70</th>\n",
              "      <td>dose-limiting toxicity (dlt)|adverse events|complete response rate|duration of response|progression free survival|objective response rate|overall survival|area under the concentration versus time curve (auc)|peak plasma concentration (cmax)|time of cmax (tmax)</td>\n",
              "      <td>880.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>891</th>\n",
              "      <td>to determine the optimal regimen of post-graft immunosuppression with high-dose cy following fludarabine, busulfan, and transplantation of fully hla-matched bone marrow that leads to an acceptable incidence of grades iii/iv acute gvhd</td>\n",
              "      <td>944.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>178</th>\n",
              "      <td>pk parameter|pd parameter</td>\n",
              "      <td>758.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>653</th>\n",
              "      <td>determine rate of dose limiting toxicities|number of participants with dose limiting toxicities to determine maximum tolerated dose.|pharmacokinetics: serum concentration of cpx-351 components (cytarabine and daunorubicin) and metabolites.|tumor measurement by bone marrow biopsy, blood counts, and/or pet/ct scan|serum levels of biomarkers (troponin-1, troponin-t, and b-type natriuretic) of cardiac injury.</td>\n",
              "      <td>2038.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>242</th>\n",
              "      <td>to determine mtd and dlt of gemcitabine oral formulation|ae/sae incidences|changes from baseline in clinical laboratory test (hematology, biochemistry, coagulation factors and urinalysis) results, vital sign measurements, physical examination findings, and ecg and 2d echocardiogram/multiple-gated acquisition (muga) scan results|characterize the pk of d07001-f4|orr(objective response rate) and tumor response</td>\n",
              "      <td>1065.0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>388</th>\n",
              "      <td>NaN</td>\n",
              "      <td>2496.0</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2d818e4f-d82c-4634-876b-48ec60c9c114')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-2d818e4f-d82c-4634-876b-48ec60c9c114 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-2d818e4f-d82c-4634-876b-48ec60c9c114');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 37
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# EFF vs non safety\n",
        "pattern = re.compile(r\"\\b(overall survival|os|pfs|progression free survival|best overall survival|bor|duration of response|cr|crr|complete response)\\b\", re.IGNORECASE)\n",
        "dff1[\"scat\"]=np.where(dff1[\"outcome_measures\"].str.contains(pattern),\"OS\" ,\"SafetySolo\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "U7ySTIFuj3iC",
        "outputId": "dbd60a92-ea30-4046-f325-719a278458ac"
      },
      "execution_count": 50,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-50-08c417cff707>:3: UserWarning: This pattern is interpreted as a regular expression, and has match groups. To actually get the groups, use str.extract.\n",
            "  dff1[\"scat\"]=np.where(dff1[\"outcome_measures\"].str.contains(pattern),\"OS\" ,\"SafetySolo\")\n",
            "<ipython-input-50-08c417cff707>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  dff1[\"scat\"]=np.where(dff1[\"outcome_measures\"].str.contains(pattern),\"OS\" ,\"SafetySolo\")\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"scat\" , y=\"duration\",palette=\"Set2\", data=dff1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "SeK7qw-rk-QN",
        "outputId": "70e2ef19-7a9f-4074-aa74-434f5d7787e6"
      },
      "execution_count": 51,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# EFF vs non safety 2\n",
        "pattern = re.compile(r\"\\b(dlt|ae|dose limit toxicity|toxicity|pk|pd)\\b\", re.IGNORECASE)\n",
        "dff1[\"dltcat\"]=np.where(dff1[\"outcome_measures\"].str.contains(pattern),\"DLT\" ,\"EFFSolo\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "XMvtInhjlPlY",
        "outputId": "9abcf19b-3cac-49c7-d932-1d16115ca4a2"
      },
      "execution_count": 47,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-47-b1a629a02016>:3: UserWarning: This pattern is interpreted as a regular expression, and has match groups. To actually get the groups, use str.extract.\n",
            "  dff1[\"dltcat\"]=np.where(dff1[\"outcome_measures\"].str.contains(pattern),\"DLT\" ,\"EFFSolo\")\n",
            "<ipython-input-47-b1a629a02016>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  dff1[\"dltcat\"]=np.where(dff1[\"outcome_measures\"].str.contains(pattern),\"DLT\" ,\"EFFSolo\")\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "fig=plt.figure()\n",
        "ax=sns.barplot(x=\"dltcat\" , y=\"duration\",palette=\"Set2\", data=dff1)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 449
        },
        "id": "Lh433mOJluln",
        "outputId": "29d38263-4093-4b15-8ec5-af4ac7eb537a"
      },
      "execution_count": 48,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import time"
      ],
      "metadata": {
        "id": "oUdrV09-gfP0"
      },
      "execution_count": 27,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "messages = [\n",
        "    # system: define chatGPT's role and the tone of chatGPT\n",
        "    {\"role\": \"system\",\n",
        "     \"content\": 'You can only use \"1\" or \"0\" as your answer. Please use your best judgement. If you are not sure about the answer, then just guess one.'},\n",
        "    # simulate conversations like https://chat.openai.com/chat\n",
        "    # assistant is chatgpt, user is us\n",
        "    {\"role\": \"user\", \"content\": \"\"\"Please read the following outcome measures include overall survive or OS. Please answer \"1\" if it is, and \"0\" if it's not.\n",
        "     The outcome measure is \"overall survival median|3-year overall survival\".\"\"\"},\n",
        "    {\"role\": \"assistant\", \"content\": \"1\"},\n",
        "    {\"role\": \"user\", \"content\": \"overall survival (os)...\"},\n",
        "    {\"role\": \"assistant\", \"content\": \"1\"}\n",
        "]\n",
        "\n",
        "chat_raw_results, correct = [], 1\n",
        "for row in train_df.iterrows():\n",
        "    outcome_measure, target = row[1]['outcome_measure'], str(row[1]['target'])\n",
        "\n",
        "    # # with feedback\n",
        "    # if correct:\n",
        "    #     content = f'''Your answer is correct. How about this tweet \"{tweet_text}\"'''\n",
        "    # else:\n",
        "    #     content = f'''Your answer is wrong. How about this tweet \"{tweet_text}\"'''\n",
        "    # messages.append({\"role\": \"user\", \"content\":content})\n",
        "\n",
        "    # without feedback\n",
        "    last_message=messages[1]\n",
        "    if last_message[\"role\"]==\"user\":\n",
        "      messages=messages[:-1]\n",
        "    messages.append({\"role\": \"user\", \"content\":outcome_measure})\n",
        "    completion = openai.ChatCompletion.create(\n",
        "        model=\"gpt-3.5-turbo\",\n",
        "        messages=messages)\n",
        "    chat_response = completion.choices[0].message.content\n",
        "    chat_raw_results.append(chat_response)\n",
        "    correct = 1 if chat_response == str(target) else 0\n",
        "    # messages.append({\"role\": \"assistant\", \"content\":chat_response})\n",
        "    time.sleep(np.random.randint(1))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 514
        },
        "id": "kvugtI5igjGH",
        "outputId": "2d446dc1-62ed-4ab1-8d0e-1dc7d31b51d0"
      },
      "execution_count": 40,
      "outputs": [
        {
          "output_type": "error",
          "ename": "KeyError",
          "evalue": "ignored",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/indexes/base.py\u001b[0m in \u001b[0;36mget_loc\u001b[0;34m(self, key, method, tolerance)\u001b[0m\n\u001b[1;32m   3801\u001b[0m             \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 3802\u001b[0;31m                 \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_engine\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget_loc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mcasted_key\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   3803\u001b[0m             \u001b[0;32mexcept\u001b[0m \u001b[0mKeyError\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0merr\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/_libs/index.pyx\u001b[0m in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[0;34m()\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/_libs/index.pyx\u001b[0m in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[0;34m()\u001b[0m\n",
            "\u001b[0;32mpandas/_libs/hashtable_class_helper.pxi\u001b[0m in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[0;34m()\u001b[0m\n",
            "\u001b[0;32mpandas/_libs/hashtable_class_helper.pxi\u001b[0m in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[0;34m()\u001b[0m\n",
            "\u001b[0;31mKeyError\u001b[0m: 'outcome_measure'",
            "\nThe above exception was the direct cause of the following exception:\n",
            "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-40-f5ec4a6d3fa7>\u001b[0m in \u001b[0;36m<cell line: 15>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     14\u001b[0m \u001b[0mchat_raw_results\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcorrect\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;36m1\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     15\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mrow\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mtrain_df\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0miterrows\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 16\u001b[0;31m     \u001b[0moutcome_measure\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtarget\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mrow\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'outcome_measure'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mrow\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'target'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     17\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     18\u001b[0m     \u001b[0;31m# # with feedback\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/series.py\u001b[0m in \u001b[0;36m__getitem__\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m    979\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    980\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mkey_is_scalar\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 981\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_get_value\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    982\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    983\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mis_hashable\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/series.py\u001b[0m in \u001b[0;36m_get_value\u001b[0;34m(self, label, takeable)\u001b[0m\n\u001b[1;32m   1087\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1088\u001b[0m         \u001b[0;31m# Similar to Index.get_value, but we do not fall back to positional\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1089\u001b[0;31m         \u001b[0mloc\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget_loc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mlabel\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1090\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_get_values_for_loc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mloc\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlabel\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1091\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/indexes/base.py\u001b[0m in \u001b[0;36mget_loc\u001b[0;34m(self, key, method, tolerance)\u001b[0m\n\u001b[1;32m   3802\u001b[0m                 \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_engine\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget_loc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mcasted_key\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   3803\u001b[0m             \u001b[0;32mexcept\u001b[0m \u001b[0mKeyError\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0merr\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 3804\u001b[0;31m                 \u001b[0;32mraise\u001b[0m \u001b[0mKeyError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0merr\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   3805\u001b[0m             \u001b[0;32mexcept\u001b[0m \u001b[0mTypeError\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   3806\u001b[0m                 \u001b[0;31m# If we have a listlike key, _check_indexing_error will raise\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mKeyError\u001b[0m: 'outcome_measure'"
          ]
        }
      ]
    }
  ]
}